日本癌治療学会誌 = The journal of Japan Society of Clinical Oncology
22(2)
日本癌治療学会 [編]
国立国会図書館雑誌記事索引 1 (1) 1966.03～;本タイトル等は最新号による;刊行頻度の変更あり;並列タイトル変遷: The journal of Japan Society for Cancer Therapy (1巻1号-32巻5号)→ The journal of Japan Society of Clinical Oncology (36巻1号-);46巻1号から46巻3号には「日本癌治療学会学術集会」49回の表示もあり;34巻から41巻まで各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会抄録号」として2分冊刊行. 42巻から46巻まで各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会抄録号」, 各巻3号は「日本癌治療学会学術集会educational book」として3分冊刊行. 47巻以降各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会educational book」として2分冊刊行;1巻1号 (Mar. 1, 1966)-;47巻3号は「JSCO」[電子資料] (USBメモリ) 50回として刊行, 48巻3号, 49巻3号は 「日本癌治療学会学術集会抄録号」 [電子資料] (USBメモリ) 51回, 52回として刊行
Presidential Lecture Diagnosis and Treatment of Bone Tumors in Japan--The History and View / I.Maeyama / p131～132
Special Lecture 1. Induction of Differentiation of Tumor Cells and an Approach to Therapy of Tumors / M.Hozumi / p133～133
Special Lecture 2. Prospect of Immunological Approaches to Diagnosis and Therapy of Cancer, Especially with Monoclonal Antibodies and Recombinant Cytokines / T.Tokunaga / p134～134
Special Lecture 3-1. Improving Cancer Treatment From the Standpoint of Basic Cancer Research / S.Takayama / p135～135
Special Lecture 3-2. Consideration on Appropriate Measures to Elevate the Cure Rate of Gastric Cancer / K.Inokuchi / p136～136
Special Lecture 4. The Role and Progress of Plastic Surgery in the Treatment of Cancers / K.Harii / p137～137
Special Lecture 5. Present Situation on Nationwide Registration of Gastric Cancer / K.Miwa / p138～140
Invitational Lecture 1. The Use of Massive Osteoarticular and Intercalary Allografts in Limb Preservation in Patients with Bone Tumors / H.J.Mankin / p141～141
Invitational Lecture 2. Not Received / /
Invitational Lecture 3. Surgical Adjuvant Therapy of Colorectal Cancer,Trials,Errors and Glimmers of Hope / C.G.Moertel / p142～154
Symposium 1 Limb Salvage Treatment for Osteosarcoma / / p155～163
1. Rationale of Preoperative Chemotherapy for Osteosarcoma / K.Furuse / p155～155
2. Limb-sparing Surgery Combined with Pre-operative Intra-arterial Infusion of Anti-cancer Agents in the Treatment of Osteosarcoma / S.Takeuchi et al. / p156～156
3. Limb Salvage for Osteosarcoma Significance of Preoperative Isolation Perfusion Chemotherapy / S.Takeyama et al. / p157～157
4. The Role of Fast Neutron Radiotherapy in the Treatment of Osteosarcoma / N.Takada / p158～158
5. Value of Limb Saving Operation in Treatment of Osteosarcoma / N.Kawaguchi et al. / p159～159
6. Application of Biomaterials for the Limb Saving Procedure of Ostesarcoma / Y.Kotoura et al. / p160～160
7. Significancy of Surgical Adjuvant Chemotherapy of Osteosarcoma / S.Yamawaki et al. / p161～161
1(1). Autologous Bone Marrow Transplantation for Osteosarcoma / M.Ohira et al. / p162～162
1(2). Functional Evaluation of Preserved Limb Following Resection of Malignant Bone Tumors Including Osteosarcoma / K.Tomita / p163～163
Symposium 2 Development of Cancer Surgery by New Medical Instruments / / p164～174
1. Surgery for Metastatic Brain Tumors with New Surgical Instruments / K.Nomura et al. / p164～165
2. Examination and Comparison between the New Therapeutic Methods Developed by Modern Engineering / A.Hohki / p166～166
3. Qualitative Improvement of Surgical Treatment for Lung Cancer Using Laser / H.Kato et al. / p167～167
4. Efficacy and Limitations of the Laser Surgery for the Malignant Tumor / F.Sano et al. / p168～168
6. Preparation of Antithrombogenic Bypass-Catheter of the Portal Vein and Its Application to the Extended Radical Operation Accompanied by Portal Vein Resection for Pancreatic Cancer / A.Nakao et al. / p170～170
7. New Operative Technique to Resect Cardiac Cancers Accompanying Lower Mediastinal Lymph Nodes Dissection through Abdomino-phrenotomy without Thoracotomy Using Improved Hook Suspender and Autosuture Instrument / K.Yoshino et al. / p171～171
8. Usage of CUSA(Cavitron Ultrasonic Surgical Aspirator)in the Radical Operation for Cervical Carcinomas of the Uterus / Y.Morishita et al. / p172～172
9. Laser Vaporization and Incisional Conization as a Conservative Therapy for a Cervical Neoplasia / K.Wakita et al. / p173～173
10. Clinical Significance of Combined Use Radiation Therapy and Hyperthermia / T.Matsuda et al. / p174～174
Symposium 3 New Device of Irradiation Method Using Conventional Radiotherapy Equipments / / p175～182
1. CT and MRI in Radiotherapy / G.Irie et al. / p175～175
2. Brachytherapy for the Cancer / M.Nishio / p176～176
3. Combination of Radiation and Drug Therapy / K.Morita / p177～177
4-(1). Total Body Irradiation as a Method of Preparation for Bone Marrow Transplantation in the Treatment of Leukemia / T.Inoue / p178～178
4-(2). The Effect of Low Dose of Total Body Irradiation on Tumor Control / K.Sakamoto et al. / p179～179
5-(1). Preoperative Radiotherapy on Brain Tumors / T.Kondo / p180～180
5-(2). Preoperative Radiotherapy Part II Adenocarcinoma of the Stomach and Breast / S.Kamimura / p181～181
II-5. Clinicopathological Study of Bone Metastasis of Gastric Cancer and Its Therapy / H.Nishidoi et al. / p203～203
II-6. Bone Metastasis of Malignant Solid Tumors in Childhood / N.Taguchi / p204～204
III-1. Diagnosis and Treatment for Metastatic Bone Cancer of the Extremity / H.Fukuma et al. / p205～205
III-2. Diagnosis and Treatment of Secondary Spine Tumors / S.Inoue / p206～206
III-3. Radiation Therapy and Diagnosis of Bone Metastasis / T.Mamiya et al. / p207～207
Workshop 1. The Effect of Cycrophosphamide for Lymphocyte Subsets Using Two Color Analysis of Monoclonal Antibody by Flow Cytometry / H.Yamagishi et al. / p208～208
Workshop 2.Pharmacokinetics of Cisplatin in Children with Malignant Solid Tumors / K.Sue et al. / p208～208
Workshop 3.Studies on Pharmacokinetics of CDDP in Gynecological Malignant Diseases / M.Murae et al. / p208～208
Workshop 4.Therapeutic Efficacy and Pharmacokinetics of Cisplatin in Patients with Non-Small Cell Lung Cancer / Y.Kusunoki et al. / p209～209
Workshop 5.Continuous Infusion Cisplatin for Neuroblastoma in Childhood / T.Hattori et al. / p209～209
Workshop 6.The Sequential Combination Chemotherapies Based on Synchronization Theory,for Urogenital Cancers / Y.Ishibashi et al. / p209～209
Workshop 7.Intraperitoneal (Ip) Cisplatinum (CDDP) Chemotherapy in Patients with Ovarian Cancer -Report III AUC of Free Platinum (Pt) and Peritoneal Clearance / M.Oku et al. / p210～210
Workshop 8.Primary Chemotherapy of Cis-Platinum for Cervical Cancer by Intraarterial Infusion / T.Izutsu et al. / p210～210
Workshop 9.Selective Intraarterial Infusion Chemotherapy of CDDP on Cervical Cancer / H.Sato er al. / p210～210
Workshop 10.Balloon Occluded Arterial Infusion Chemotherapy with CDDP for the Treatment of Malignant Bone and Soft Tissue Tumors / Y.Tomizawa et al. / p211～211
Workshop 11.A Study of Two Ways of Administration of CDDP Powder to Patients with Hepatocellular Carcinoma / J.Shindo et al. / p211～211
Workshop 12.Trans-arterial Infusion Chemotherapy Using Multi-anticancer Agents Suspended in Lipiodol / H.Taniguchi et al. / p211～211
Workshop 13.Pharmacokinetic Study of Two Route Chemotherapy / R.Abe et al. / p212～212
Workshop 14.Pharmacokinetics of CISPLATIN with STS Administration / S.Matsumoto et al. / p212～212
Workshop 15.The Side Effects Following Intraperitoneal (IP) Administration of DDP with or without STS with Special Reference to Serum and Ascitic Levels of the Free CDDP / K.Takizawa et al. / p212～212
Workshop 17.Anti-tumor Activity and Side Effect of IpTCC in the Treatment of Ovarian Carcinoma / N.Kawai et al. / p213～213
Workshop 18.An Analytical Study on the Mechanism of Coenzyme Q₁₀ Enhancement of the Effect of Adriamycin in Cultured Mouse Sarcoma Cells / K.Toda et al. / p213～213
Workshop 19.The Experimental Study for Continuous Hepatic Arterial or Portal Infusion Therapy Using Adriamycin against Metastatic Liver Tumor / T.Mori et al. / p214～214
Workshop 20.An Evaluation of the Plasma Concentration of Anticancer Agents Following One Shot Therapy and Transcatheter Arterial Embolization (TAE) Therapy in Hepatocellular Carcinoma / Y.Aoki et al. / p214～214
Workshop 21.A Study on Effect of Calcium Antagonist (Verapamil)--Concentration in Blood, Side Effect and Anticancerous Effect in Its Combined Use with Adriamycin, Vincristine and Vinblastin / S.Iwabuchi et al. / p214～214
Workshop 22.Intravesical Chemotherapy for Bladder Cancer by Adriamycin Adhering to Bladder Mucosa / K.Ueda et al. / p215～215
Workshop 23.Pharmacokinetics of 5-FU in Various Administration Methods / H.Fujita et al. / p215～215
Workshop 24.Not Received / /
Workshop 25.Characteristic Pharmacodynamics of 1-Hexylcarbamoyl-5-fluorouracil (HCFU) Metabolism after Oral Administration in Cirrhotics with Hepatocellular Carcinoma / K.Takenaka et al. / p215～215
Workshop 26.Clinicopathological Study of Gastric Cancer after Neoadjuvant Sequential Therapy of MTX-5FU / S.Minaguchi et al. / p216～216
Workshop 27.The Significance of the Presensitization before Intratumor Injection of OK-432 in Gastric Cancer Patients / A.Gochi et al. / p216～216
Workshop 28.Intraperitoneal Administration of β-interferon in Gastric Cancer Patients with Peritoneal Recurrence (Values of Ascites and Serum IFN Levels and Its Antitumor Effect) / T.Notsuka et al. / p216～216
Workshop 29.Intracavitary Administration of Recombinant Interferon-β in Cancer Patients with Malignant Effusion / M.Tanada et al. / p217～217
Workshop 30.In vivo, Antitumor Effect of Receptor Mediated Agent,Neocarzinostatin-Transferrin Conjugate against Heterotransplanted Human Colon Carcinoma in Nude Mice / J.Kato et al. / p217～217
Workshop 31.Pharmacological Study of Cisplatin and Carboplatin:A New Method for Evaluation of Analogues by Bioassay Using Clonogenic System / Y.Sasaki et al. / p217～217
Workshop 32.A New Trial of Treatment of Gastric Cancer with Aclarubicin / D.Kagawa et al. / p218～218
Workshop 33.K-18, Conjugate of Human IgG and Melphalane Accumulates Selectively into the Tumor / K.Ohgaki et al. / p218～218
Workshop 34.Chemotherapy for Carcinomatous Peritonitis and Pleuritis Using Anticancer Agents Adsorbed on Activated Carbon Particles / A.Hagiwara et al. / p218～218
Workshop 35.Adjuvant Chemotherapy with Prolonged Releasing Microcapsule Encapsulated Anticancer Drug / H.Mori et al. / p219～219
Workshop 36.Intraarterial Infusion Therapy Using Polysaccharide Solution as a Carrier of Anticancer Drugs / T.Shimizu et al. / p219～219
Workshop 37.Hepatic Arterial Infusion Chemotherapy of FAM in Metastatic Liver Cancer(2nd Report) / Y.Arai et al. / p219～219
Workshop 38.Clinical Trial of Degradable Starch Microspheres (DSM) in the Treatment of Hepatomas by Intra-arterial Infusion of Anticancer Drugs / T.Yamada et al. / p220～220
Workshop 39.Intra Arterial Superselective ACNU Administration for Malignant Glioma / Y.Tokuriki et al. / p220～220
Workshop 40.Study Intra Arterial Chemoembolization of Advanced Ovarian Cancer / J.Kumagai et al. / p220～220
Workshop 41.Pharmacokinetic Study of Anticancer Drug under Induced Hypertension Chemotherapy / M.Okamoto et al. / p221～221
Workshop 42.The Intracisternal Injection of ACNU for Malignant Leptomeningeal Tumor / S.Koh et al. / p221～221
Workshop 43.The Effect of Neoadjuvant Chemotherapy for Malignant Bone and Soft Tissue Tumors / H.Kawano et al. / p221～221
Workshop 44.Chemical Lymph Node Dissection for Stomach Cancer / O.Kobayashi et al. / p222～222
Workshop 45.Investigations on Newly Designed Chemotherapy According to Pharmacokinetics of Anticancer Agent for Cancer of the Esophagus / T.Uchiyama et al. / p222～222
Workshop 46.Not Received / /
Workshop 47.Mass Screenings of Cervical Cancer by Practitioner System in Fukuoka Prefecture / S.Yoh et al. / p222～222
Workshop 48.Population Screening of Cervical Cancer on 3,000 Cases Using Computerreized Flow Cytometry / M.Sone et al. / p223～223
Workshop 49.The Present Condition and the Problem of Mass Screening for Carcinoma of the Cervix / H.Iwasaki et al. / p223～223
Workshop 50.The Point at Issue of Mass Screening for Uterine Cervical Cancer--Assessment of the Setting Up the"Model Area" / K.Takahashi et al. / p223～223
Workshop 51.Studies on Mass Screening for Cervical Cancer in Shiga Prefecture / J.Matsumoto et al. / p224～224
Workshop 52.The Field Trial for Early Detection of Ovarian Cancer Patients / H.Kobayashi et al. / p224～224
Workshop 53.Not Received / /
Workshop 54.Present Situation and Problems of Mass Examination--With Special Reference to Evaluation of Overlooked Cases and Self-examination / S.Ito et al. / p224～224
Workshop 55.The Significance of Cytologic Examination of Nipple Discharge on Detection or Breast Cancer by Mass Screening / M.Kimura et al. / p225～225
Workshop 56.Mass Screening of Breast Cancer in Yokohama City / H.Gotoh et al. / p225～225
Workshop 57.Mass Screening of Breast Cancer in Kanagawa Prefecture(7th Report) / Y.Takasu et al. / p225～225
Workshop 58.Mass Screening for Breast Cancer in Kyoto City--The Role of Palpitation and Ultra Sonography / K.Sawai et al. / p226～226
Workshop 59.Concurrent Mass Screening for Breast and Thyroid Cancer in Gunma Prefecture / T.Ishida et al. / p226～226
Workshop 60.The Present Situation and Problems of Mass Screening Systems of GI Tract in Japan / T.Yamada et al. / p226～226
Workshop 61.General Mass Screening for Digestive Disease with Upper GI X-ray,Occult Blood Test,Ultrasonography and Blood Test / Y.Saito et al. / p227～227
Workshop 62.Present Status and Problems in Mass Screening of Hepatic Disease / T.Watayo et al. / p227～227
Workshop 63.The Useful Method of Us Mass-Screening to Detect Hepatocellular Carcinoma(HCC) / T.Sakai et al. / p227～227
Workshop 64.Problems in Sputum Cytology Mass Survey for Lung Cancer Detection / C.Konaka et al. / p228～228
Workshop 65.Results and Problems of Lung Cancer Mass Survey in Okayama / T.Tamura et al. / p228～228
Workshop 66.Occurrence and Counterplan of Prostatic Diseases in Keihoku-cho Town / M.Nakao et al. / p228～228
Workshop 67.Mass Screening of the Prostate by Rectal Examination,Serum Acid Phosphatase and Transrectal Ultrasonography / S.Ishikawa et al. / p229～229
Workshop 68.Cancer Control Programs in Miyagi Prefecture--The Actual Condition and Future Approach / S.Hisamichi et al. / p229～229
Workshop 69."Field Carcinogenesis"in Patients with Head and Neck Squamous Cell Carcinoma / H.Shibuya et al. / p229～229
Workshop 70.The Role of Ratio of Androgen to Corticosteroid in the Environmental Factor of Breast Cancer / Y.Nakamura et al. / p230～230
Workshop 71.Obesity and Sex Hormones as a Risk Factor of Breast Cancer / Y.Murayama et al. / p230～230
Workshop 72.Malignant Potential of Gastric Cancer as Function of Sex and Age / H.Furukawa et al. / p230～230
Workshop 73.Immunological Activity of Peripheral Blood Lymphocytes(PBL)and Regional Lymphnode Lymphocytes(LNL)of Cancer Patients / W.Ugajin et al. / p231～231
Workshop 74.Adoptive Immunotherapy(AIT)Using Regional Lymph Node Lymphocytes Cultured with IL-2 / T.Okino et al. / p231～231
Workshop 75.Immunohistochemical Study of Regional Lymph Nodes in Gastric and Breast Cancers / S.Amano et al. / p231～231
Workshop 76.Immunocompetence in Regional Lymph Nodes of Esophapeal Cancer / M.Oka et al. / p232～232
Workshop 77.Host Immune Responses in Regional Lymph Nodes of Gastric Cancer Patients / T.Inagaki et al. / p232～232
Workshop 78.Analysis of Regional Lymphnode T-Lymphocyte Subsets in Patients with Gastric Cancer / S.Togo et al. / p232～232
Workshop 79.Cell-mediated Cytotoxic Activity of Regional Lymph Node Cells(LNC)from Patients with Gastric Carcinoma / F.Koba et al. / p233～233
Workshop 80.Augmentation of Cytotoxicity of Regional Lymph Node Lymphocytes of Gastric Cancer by Intratumoral Injection of Recombinant Interleukin 2 / G.Kobayashi et al. / p233～233
Workshop 81.Effects of Oral OK432 in Gastric Cancer Patients / Y.Nio et al. / p233～233
Workshop 82.Effects of the Intratumoral Administration of OK-432 through an Endoscope on the Immunological Response of Regional Lymphnodes in Early Gastric Cancer / T.Katsube et al. / p234～234
Workshop 83.Study of the Cellular Immunological Competence of Regional Lymphnodes in Colon Cancer / N.Matsumoto et al. / p234～234
Workshop 84.Distribution of Natural Killer Cell in Regional Lymphnode of Colorectal Cancer / W.Adachi et al. / p234～234
Workshop 85.Cytotoxic Activity of IL-2 Stimulated Regional Lymphnode Lymphocytes against Autologous Lung Cancer Cells / H.Kimura et al. / p235～235
Workshop 86.Immunomorphologic Changes of Regional Lymph Nodes in Uterine Cervical Cancer / M.Kinugasa et al. / p235～235
Workshop 87.Immunological Competance of Regional Lymph Nodes in Breast Cancer Patients / T.Aono et al. / p235～235
Workshop 88.Sinus Histiocytosis of Regional Lymph Nodes in Patients with Breast Carcinoma / M.Takeuchi et al. / p236～236
Workshop 89.Study of the Immunological Competence of Regional Lymphnodes in Breast Cancer / T.Shimizu et al. / p236～236
Workshop 90.Clinical and Fundamental Investigations into Immunological Defence Mechanism against Metastasis to Axillary Lymph Nodes in Breast Cancer Patients / Y.Nakajima et al. / p236～236
Workshop 91.Influence of Aging on Immune Activity of Regional Lymph Nodes in Breast Cancer / H.Matsukawa et al. / p237～237
Workshop 92.Therapeutic Planning of Stages II and IVS Neuroblastoma According to the Amplifi-cation of N-myc Oncogene / A.Nakagawara et al. / p237～237
Workshop 93.Role of Surgery in the Multimodal Therapy of Advanced Neuroblastoma / Y.Hata et al. / p237～237
Workshop 94.An Evaluation of the Therapeutic Results of Solid Malignant Tumors in Children / S.Ogita et al. / p238～238
Workshop 95.A Group Study for the Establishment of Treatment Protocols for Advanced Neuro-blastoma / S.Sawaguchi et al. / p238～238
Workshop 96.Multidisciplinary Treatment Studies on Wilms′Tumor in Kitakanto Region / H.Muchi et al. / p238～238
Workshop 97.Effects of High-Dose Methotrexate on Gonadal Functions in Children of Osteosar-coma / A.Yokogawa et al. / p239～239
Workshop 98.New Device for Immobilisation of Young Children in the Proton Irradiation Therapy / H.Ohkawa et al. / p239～239
Workshop 99.The Role of Radiotherapy in Pediatric Oncology / T.Watari et al. / p239～239
Workshop 100.Bone Marrow Transplantation in Pediatric Solid Tumor / S.Yokoyama et al. / p240～240
Workshop 101.A Comparative Study of Mitoxantrone(MXT)and Adriamycin(ADM)in Patients with Non-Hodgkin's Lymphoma(NHL): A Cooperative Study / T.Ohnoshi et al. / p240～240
Workshop 102.Alternating Combination Chemotherapy with THP-COP and BHAC-VMP in Non-Hodgkin′s Lymphoma(NHL) / K.Ezaki et al. / p240～240
Workshop 103.A New Salvage Chemotherapy for Refractory Non-Hodgkin′s Lymphoma (NHL) with 4-drug Combination of Mitoxantrone,Etoposide,Cisplatin and Prednisolone(MEPP) / K.Ueno et al. / p241～241
Workshop 104.A System of Medical Examination and Multi-Modal Treatment for Non Hodgkin's Lymphoma / T.Yoshida et al. / p241～241
Workshop 105.Results of Radiation Therapy for Extranodal Non-Hodgkin′s Lymphoma in the Head and Neck A Study of Japan Lymphoma Radiation Therapy Study Group / J.Horiuchi et al. / p241～241
Workshop 106.Treatment of Primary Extranodal Lymphoma / M.Nishikori et al. / p242～242
Workshop 107.Multi-Modal Treatment for Extranodal Malignant Lymphoma / E.Sanuki et al. / p242～242
Workshop 108.Treatment for Primary Malignant Lymphoma in the Digestive Tract / N.Sakata et al. / p242～242
Workshop 109.Chemotherapy for High Grade and Refractory NHL with M-BACOD and Its Modified Regimen / H.Ogata et al. / p243～243
Workshop 110.The Intermediate Dose of Cytosine Arabinoside(IDara-C)in the Treatment of Refractory Acute Leukemia / N.Inagaki et al. / p243～243
Workshop 111.Low-Dose 4N-Behenoyl-β-D-Arabinofuranosylcytosine(LD-BHAC)in the Treatment of Atypical Leukemia / H.Nakada et al. / p243～243
Workshop 112.Retinoid in the Treatment of Atypical Leukemia / H.Tsutani et al. / p244～244
Workshop 113.Effect of the Chemotherapy for ATL with Cyclophosphamide, Vindesine and Pred-nisolone(CV′P) / K.Uozumi et al. / p244～244
Workshop 114.The Role of Total Skin Electron Beam Irradiation in the Treatment of Adult T Cell Leukemia(ATL) / M.Nakano et al. / p244～244
Workshop 115.Surgical Treatment for Spinal Metastasis / H.Matsuzaki et al. / p245～245
Workshop 116.Surgical Treatment of Metastatic Spinal Tumor / S.Uchiyama et al. / p245～245
Workshop 117.Treatment of Metastatic Spinal Tumors by Posterior Stabilization with Instrumentation / M.Murase et al. / p245～245
Workshop 118.A Guideline of Surgical Treatment for Metastatic Spinal Tumor / K.Yonenobu et al. / p246～246
Workshop 119.Prosthetic Replacement Surgery for Metastatic Spinal Tumor / K.Ono et al. / p246～246
Workshop 120.Management for Metastatic Spinal Tumors / S.Tatezaki et al. / p246～246
Workshop 121.Posterior Decompression and Stabilization for Malignant Spinal Tumor / Y.Miyaji et al. / p247～247
Workshop 122.Surgical Treatment for Primary Spine Tumor / H.Kitahara et al. / p247～247
Workshop 123.Reconstructive Surgery with Spinal Instrumentation for Spinal Tumor / K.Abumi et al. / p247～247
Workshop 124.Surgery of Huge Tumors of the Sacrum:From Approach to Reconstruction / K.Tomita et al. / p248～248
Workshop 125.Surgical Treatment of Bone and Soft Tissue Tumors in Pelvic Region / H.Takahashi et al. / p248～248
Workshop 126.Usefulness of High Resolution MRI in the Diagnosis of Spinal Dissemination of Intracranial Gliomas / J.Yamashita et al. / p248～248
Workshop 127.Treatment of Cervical Spinal Cord Tumors by En-Bloc Laminoplasty / Y.Katoh et al. / p249～249
Workshop 128.Malignant Tumors in the Spinal Epidural Space--Methods and Results of Treatment of 11 Cases / A.Imakiire et al. / p249～249
Workshop 129.Surgical Treatment for Spinal Cord Tumor / K.Masaki et al. / p249～249
Workshop 130.The Results of Surgical Treatment of Spinal Cord Tumor / Y.Tokuhashi et al. / p250～250
Workshop 131.Effect of New Technic for Primary Spinal Cord Tumor / T.Homma et al. / p250～250
Workshop 132.Image Diagnosis of Malignant Melanoma with In-111-Monoclonal Antibody 96.5 / H.Oyamada et al. / p250～250
Workshop 133.Experience of Combination Chemotherapy with DTIC,ACNU and VCR in Malignant Melanoma of Oral and Maxillofacial Region / Y.Mizutani et al. / p251～251
Workshop 134.Multidisciplinary Treatment for Malignant Melanoma of the Head and Neck / H.Saito et al. / p251～251
Workshop 135.Combination Chemotherapy(DTIC,ACNU and VCR)and Cryosurgery for Cases of Primary Malignant Melanoma of the Female Genital Tract / A.Takahashi et al. / p251～251
Workshop 136.Results of Cumulative Therapy for Cutaneous Malignant Melanoma in Our Clinic / T.Arao et al. / p252～252
Workshop 137.Recent Advances for Radiation Therapy in the Treatment of Malignant Melanoma--Fast Neutron Radiation and Hyperthermia in Combination with Radiation / S.Mori et al. / p252～252
Workshop 138.The Status of Combined Chemotherapy for Malignant Melanoma / K.Ishihara et al. / p252～252
Workshop 139.5 Year Survival Rate of Cervical Esophageal Cancer / M.Uchida et al. / p253～253
Workshop 140.The Survival Rates for Gastric Cancer Patients Who Underwent Surgical Operations / J.Fujimoto et al. / p253～253
Workshop 141.Post-operative Cumulative Survival Rate in Patients with Gastric Cancer / K.Inoue et al. / p253～253
Workshop 142.Factors Affecting Therapeutic Efficacy and Survival of Advanced Gastric Cancer Patients on Cancer Chemotherapy / H.Takahashi et al. / p254～254
Workshop 143.The Problems of Postoperative Adjuvant Chemotherapy for Gastric Cancer / Y.Kunii et al. / p254～254
Workshop 144.Clinical Evaluation of Postoperative Adjuvant Chemotherapy for the Gastric Cancer / K.Takesita et al. / p254～254
Workshop 145.Results of Surgical Treatment and Effects of Chemo-Endocrine Therapy with Tamox-ifen(TAM)for Gastric Scirrhus(Diffuse Carcinoma of the Stomach) / S.Nakamura et al. / p255～255
Workshop 146.Effect of Hyperthermo-chemotherapy with Continuous Hyperthermic Peritoneal Perfusion(CHPP)with General Hypothermia on the Survival Rate of Gastric Cancer / Y.Masuda et al. / p255～255
Workshop 147.Significance of Reduction Surgery on Colo-rectal Cancer / M.Ikeguchi et al. / p255～255
Workshop 148.Clinical Effect of PSK as an Adjuvant Immunochemotherapy after Radical Operations of Colorectal Cancer--Colon Cancer Chemotherapy Study Meeting in Hokuriku / S.Takashima et al. / p256～256
Workshop 149.Surgical Results in Patients with Rectal Cancer / T.Kato et al. / p256～256
Workshop 150.Cumulative Survival Rates of Hepatectomies for Hepatocellular Carcinoma / M.Suenaga et al. / p256～256
Workshop 151.An Assessment of the Therapeutic Effects of One Shot Therapy and Transcatheter Arterial Embolization in Unresectable Hepatocellular Carcinoma / K.Hirai et al. / p257～257
Workshop 152.Transcatheter Therapy for Unresectable Hepatocellular Carcinoma / K.Yasumori et al. / p257～257
Workshop 153.Combined Modality Treatment for Lung Cancer and Its Survival / M.Ohta et al. / p257～257
Workshop 154.Immediate Simultaneous Reconstruction in the Treatment of Primary Carcinoma of the Breast / H.Yamamoto et al. / p258～258
Workshop 155.Adjuvant Chemotherapy and Radiotherapy for Operable Breast Cancer / T.Kobayashi et al. / p258～258
Workshop 156.Clinicopathologic Study of Cervical Adenocarcinoma / I.Konishi et al. / p258～258
Workshop 157.Analysis of Prognostic and Loco-Control Factor in Uterine Cervix Cancer with Radiation Therapy / Y.Kikuchi et al. / p259～259
Workshop 158.Radiotherapy System and Survival Calculation of a Treated Patients in the National Cancer Center Hospital / S.Egawa et al. / p259～259
Workshop 159.Changes of Treatment and Improvement of 5-year Survival Rate in Adenocarcinoma of the Ovary / Y.Tomoo et al. / p259～259
Workshop 160.Analysis of 117 Dead Cases of Ovarian Malignancies / T.Kano et al. / p260～260
Workshop 161.Controlled Clinical Trials of Chemotherapy in Ovarian Cancer / H.Tamura et al. / p260～260
Workshop 162.Radiation Therapy versus Endocrine Therapy for Stage C Carcinoma of the Prostate / H.Moriyama et al. / p260～260
Workshop 163.Evaluation of Adjuvant Chemotherapy(AC)for Osteosarcoma(os)Mainly with Adriamycin(ADR) (Final Report)Japanease Orthopaedic Oncology Group / K.Furuse et al. / p261～261
Workshop 164.Prognostic Study on Patients with Osteosarcoma for Past 30 Years of Experience / H.Tsuchiya et al. / p261～261
Workshop 165.Treatment and Prognosis of Malignant Fibrous Histiocytoma of Bone / M.Itagaki et al. / p261～261
Workshop 166.Evaluation of Prognostic Factors Related to Results of Treatment for Malignant Soft Tissue Tumors / T.Ishida et al. / p262～262
Workshop 167.Effect of Circumstances of Organs on the Grade of Cancer Malignancy / T.Nakamura et al. / p262～262
Workshop 168.Invasive Property of Brain Tumor Cells in vitro--Correlation between Malignancy and Invasiveness Using Invasion Test / T.Okumura et al. / p262～262
Workshop 169.Grading of Malignancy in Patients with Squamous Cell Carcinoma of the Tongue / H.Hiratsuka et al. / p263～263
Workshop 170.Correlation between Histological Type and Epidermal Growth Factor Receptor of the Thyroid Tumor / H.Masuda et al. / p263～263
Workshop 171.The Prognostic Value of Flow Cytometric DNA Analysis in Human Esophageal Carcinomas / K.Sanekata et al. / p263～263
Workshop 172.Expression of EGF Receptors on Esophageal Carcinomas, Compared with Other Tumor Markers / S.Ikeuchi et al. / p264～264
Workshop 173.Malignancy of Gastric Cancer According to DNA Ploidy Pattern and Tumor Markers / K.Sugiyama et al. / p264～264
Workshop 174.A Study of Nuclear DNA Ploidy Patterns of Gastric Carcinoma / H.Yosino et al. / p264～264
Workshop 175.Mitotic Activity of Cancer Cells and Survival of Gastric Cancer Patients / Y.Tabuchi et al. / p265～265
Workshop 176.Malignancy of the Stomach Cancer Decided by the Tumor Volume Doubling Time,the Transplantability into Nude Mice and the Capacity of Protein Synthesis in vitro / K.Bando et al. / p265～265
Workshop 177.Correlation of CEA Tissue and Serum Positivity in Gastric Cancer Patients / R.Kirchner et al. / p265～265
Workshop 178.Malignant Characteristic and Prognosis of Gastric Cancer Evaluated from Serum Glycoproteins / K.Ogoshi et al. / p266～266
Workshop 179.A Study on Mitotic Activity of Human Gastric and Colorectal Cancers / K.Imanishi et al. / p266～266
Workshop 180.Clinicopathological Significance of Tissue Human Chorionic Gonadotropin(hCG)in Colorectal Carcinoma / T.Kosaka et al. / p266～266
Workshop 181.Microangiographic Study on the Evolution of Colorectal Cancer / T.Shimoyama et al. / p267～267
Workshop 182.Comparative Study of Doubling Time between Gastroenterological Cancer / Y.Takahashi et al. / p267～267
Workshop 183.Not Received / /
Workshop 184.Flow Cytometric Cellular DNA-RNA Analysis in Primary Lung Cancer and Its Relationship to Early Relapse and Malignant Intensity / N.Yamaoka et al. / p267～267
Workshop 185.Estrogen Receptor and Progesterone Receptor as a Biological Marker of Breast Cancer / T.Ikeda et al. / p268～268
Workshop 186.Prognostic Value of Histochemical Analysis of Endogenous Estrogen(E2),Car-cinoembryonic Antigen(CEA)and Tissue Polypeptide Antigen(TPA)in Primary Breast Cancer / T.Yoshida et al. / p268～268
Workshop 187.Flow Cytometric Cellular DNA-RNA Analysis in Human Breast Carcinomas / S.Hara et al. / p268～268
Workshop 188.Relationship between Nuclear DNA Content,Lymph Node Metastasis and Prognosis in Breast Cancer / T.Nishi et al. / p269～269
Workshop 189.Differences of Prognosis and Invasive Patterns in Accordance with Histological Types / K.Mizuno et al. / p269～269
Workshop 190.A Correlation between Miscellenous Histopathological Factors and Prognosis in Cases of Ovarian Serous Cystadenocarcinoma / M.Tashiro et al. / p269～269
Workshop 191.Ploidy and Proliferation in Human Bladder Carcinomas as Measured by Two-parame-ter DNA-RNA Microspectrophotometric Analysis and Its Relations to Histopathology and Clinical Course / K.Naito et al. / p270～270
Workshop 192.Factors Relating to Malignant Potential of Grade 2 TCC of the Urinary Bladder / M.Moriyama et al. / p270～270
Workshop 193.Relationship between Cell Nuclear DNA in Tissues from Patients with Osteosarcoma and the Prognosis / S.Masuda et al. / p270～270
Workshop 194.Microphotometric Analysis of Two Leiomyosarcomas of Bone and Soft Tissue with Progressive Histological Change in Clinical Course / H.Itoh et al. / p271～271
Workshop 195.Radiofrequency Capacitive Hyperthermia Combined with Radiotherapy for Locally Advanced and Recurrent Colorectal Cancer / Y.Nishimura et al. / p271～271
Workshop 196.Preoperative Treatment with Pelvic Radiation plus 5-Fluorouracil Suppository for Rectal Cancer / M.Niwa et al. / p271～271
Workshop 197.Application of Laser for the Rectal Cancer / O.Nishida et al. / p272～272
Workshop 198.Sphincter Preserving Operation for Cancer of the Lower Rectum / S.Kodaira et al. / p272～272
Workshop 199.Multimodal Treatment of Colorectal Cancer--Experience of Intraoperative Radiation Therapy with or without Preoperative Irradiation / T.Okawa et al. / p272～272
Workshop 200.Extended and Limited Procedures in Surgery of Lower Rectal Cancer / K.Hojo et al. / p273～273
Workshop 201.Indication and Evaluation of Endoscopic Laser Therapy in Lung Cancer / R.Ono et al. / p273～273
Workshop 202.Evaluation of Preoperative Photodynamic Therapy for the Lung Cancer / N.Kawate et al. / p273～273
Workshop 203.Co 60 Remote Afterloading Intracavitary Irradiation to the Tracheo-bronchial Cancer Infiltration / T.Kawaguchi et al. / p274～274
Workshop 204.The Evaluation of Photodynamic Therapy(PDT)with Hematoporphyrin Derivatives(HpD)in Inoperable Patients with Stage Ia Hilar Type Lung Cancer--Comparison of PDT with Radiation Therapy(RT) / K.Furuse et al. / p274～274
Workshop 205.Uneven Fractionation in the Radiation Therapy Combined with Cisplatin for Lung Cancer / Y.Takai et al. / p274～274
Workshop 206.A Phase II Study of Epirubicin in Lung Cancer / M.Kawahara et al. / p275～275
Workshop 207.Study on a Long-term Adjuvant Chemotherapy for Lung Cancer / M.Imaizumi et al. / p275～275
Workshop 208.A Randomized Trial of Chemotherapy Alone or with Chest Irradiation in Limited Stage Small Cell Lung Cancer(SCLC) / S.Kawahara et al. / p275～275
Workshop 209.A Randomized Study of the Alternating Noncross Resistant Chemotherapy for the Patients with SCLC / M.Takada et al. / p276～276
Workshop 210.Not Received / /
Workshop 211.Not Received / /
Workshop 212.A Randomized Trial Comparing Cisplatinum,Vindesine and Bleomycin vs Mitomycin C,Vindesine and Bleomycin in Patients with Advanced Non-Small Cell Lung Cancer / K.Nishii et al. / p276～276
Workshop 213.Combination Chemotherapy of Cisplatin, Vindesine and Mitomycin C(CVM)for Non-Small Cell Lung Cancer / M.Fukuoka et al. / p276～276
Workshop 214.Combination Chemotherapy for Non-Small Cell Lung Cancer with Cisplatin,Vinblas-tine and 5-fluorouracil / K.Aiba et al. / p277～277
Workshop 215.Cisplatin and Vindesine Chemotherapy for Advanced Non-Small Cell Lung Cancer / T.Shinkai et al. / p277～277
Workshop 216.Evaluation of Postoperative Immunochemotherapy for Non-Small Cell Lung Cancer Patients by T,N Factors / T.Ikeda et al. / p277～277
Workshop 217.Clinical Trials of Local Hyperthermia in the Treatment of Peripheral Type Lung Cancers and Lung Cancer with Malignant Effusion / R.Amemiya et al. / p278～278
Workshop 218.Percutaneous CT Guided Intratumor Injection(CT-ITI)of Absolute Ethanol for Peripheral Lung Cancer / Y.Shinohara et al. / p278～278
Workshop 219.Lymphocyte Subsets of Senile Patients with Cancer / H.Mugitani et al. / p278～278
Workshop 220.Risk Factor of Operation in Aged Patients with Cancer / K.Manabe et al. / p279～279
Workshop 221.Clinical Study on Brain Tumors in the Aged / T.Kodama et al. / p279～279
Workshop 222.Therapeutic Results of High Aged Head and Neck Tumor Patients / G.Mizojiri et al. / p279～279
Workshop 223.Treatment Results of Radiation Therapy for Head and Neck Cancer in the Patients with Advanced Age / N.Masaki et al. / p280～280
Workshop 224.Surgical Treatment for Eldery Patients with Carcinoma of the Esophagus / M.Kitamura et al. / p280～280
Workshop 225.Treatment of Cancer of Cardiac Area in the Aged Patients / Y.Kawaura et al. / p280～280
Workshop 226.Surgical Treatment of Gastric Cancer on Patients over 80 Years / S.Waki et al. / p281～281
Workshop 227.Evaluation of Surgical Treatment and Prognosis for Gastric Cancer in the Aged / H.Ueda et al. / p281～281
Workshop 228.Colorectal Carcinoma in Aged Patients / T.Ikehara et al. / p281～281
Workshop 229.Surgical Treatment of Colorectal Cancer in Patients over the Age of 80 Years / I.Fukuda et al. / p282～282
Workshop 230.Experiences in the Surgical Treatment of Colorectal Cancer in the Elderly over Seventies / Y.Yamamoto et al. / p282～282
Workshop 231.Surgical Results in Elderly Cases with Rectal Cancer / T.Sekine et al. / p282～282
Workshop 232.Actualities and Problems of Hepatic Resection of Hepatocellular Carcinoma in the Aged Patients / M.Nonaka et al. / p283～283
Workshop 233.Clinicopathological Study of High Aged Patients(over 70 Yrs Old)with Gallbladder Carcinoma / A.Kawaguchi et al. / p283～283
Workshop 234.Indication and Significance of Pancreatoduodenectomy for Advanced-aged Patients / K.Yamamoto et al. / p283～283
Workshop 235.A Clinical Study of Surgery for Bronchogenic Carcinoma in the Elderly / K.Kawahara et al. / p284～284
Workshop 236.Surgical Treatment of Lung Cancer in the Elderly / S.Kosaba et al. / p284～284
Workshop 237.The Efficiency of Intensive Combination Chemotherapy for Lung Cancer in the Elderly / N.Hara et al. / p284～284
Workshop 238.Treatment of Extensive-Stage Small Cell Carcinoma of the Lung in the Aged Patients / S.Hiraki et al. / p285～285
Workshop 239.Characteristics and Prognosis of the Breast Cancer on Older than 70 Years Women / K.Kanda et al. / p285～285
Workshop 240.Studies on Uterine Cervical Cancer Patients over 70-Years Old / H.Noguchi et al. / p285～285
Workshop 241.Treatment of Ovarian Malignancies / H.Nishimura et al. / p286～286
Workshop 242.Treatment of Bladder Cancer in Elderly Patients / T.Okano et al. / p286～286
Workshop 243.Treatment for the Elderly Patients with Bladder Cancer / H.Kivohara et al. / p286～286
Workshop 244.Treatment for Bladder Cancer in Elderly Patients / K.Ohmura et al. / p287～287
Workshop 245.Measures for Cancer Pain in Patients with Terminal Stage Lung Cancer--Effect of "Brompton Mixture" / K.Ninomiya et al. / p287～287
Workshop 246.Relief of the Pain of Unresectable Pancreatic Carcinoma by Intraoperative Irradiation and Intraoperative Chemical Splanchniectomy / Y.Suzuki et al. / p287～287
Workshop 247.The Treatments of Advanced Pancreatic Cancer / Y.Yokoyama et al. / p288～288
Workshop 248.Radiotherapy for Metastatic Bone Tumor / T.Yokote et al. / p288～288
Workshop 249.Vertebral Body Replacement for Metastatic Tumor of the Spine / E.Shimozaki et al. / p288～288
Workshop 250.Laser Stimulation Therapy Using a Diode Laser to Relieve Cancer-associated Pains / H.Shinohara et al. / p289～289
Workshop 251.Case Reports of CT Guided Celiac Nerve Plexus Block for Cancer Pain / T.Sanda et al. / p289～289
Workshop 252.Not Received / /
Workshop 253.WHO Method for Relief of Cancer Pain and the Result of the Field-testing in Japanese Cancer Patients / F.Takeda et al. / p289～289
Workshop 254.Factors of Rejection to the Treatment of Retinoblastoma / T.Mizuguchi et al. / p290～290
Workshop 255.Surface-cooling Hypothermic Anesthesia for CHPP (Continuous Hyperthermic Peri-toneal Perfusion) / M.Utsugi et al. / p290～290
Workshop 256.The Retrospective Studies on the Prognosis of Oncologic Emergency Operation / K.Hiraga / p290～290
Workshop 257.Familial Clustering of Head and Neck Tumor / M.Fujii et al. / p291～291
Workshop 258.Family Carcinogenesis in the Head and Neck Region / Y.Matsumura et al. / p291～291
Workshop 259.Familial Occurrence of Differentiated(Non-medullary)Thyroid Carcinoma / O.Ozaki et al. / p291～291
Workshop 260.Development of Cancers of the Large Intestine in One Family Line of Familial Polyposis / H.Isai et al. / p292～291
Workshop 261.Familial Non-polypotic Colorectal Cancer / H.Tomoda et al. / p292～292
Workshop 262.Study of the Influence of Family History on the Incidence of Breast Cancer / T.Koida et al. / p292～292
Workshop 263.The Cases of Renal Cancer Occurred in a Family / A.Matsubara et al. / p293～293
Workshop 264.Clinical Investigation of Familial Clustering of Cancer / T.Nomizu et al. / p293～293
Workshop 265.A Case of Non-simultaneous Five Primary Cancers in Different Organs and Her Offspring with Colorectal Cancers / A.Tokunaga et al. / p293～293
Workshop 266.Spontaneous Regression of Hepatocellular Carcinoma A Case Report / M.Suzuki et al. / p294～294
Workshop 267.Pathohistological and Immunological Research of Spontaneous Regression or Long Survival Cancer Cases (XII) -The Analytical Study of the Malignant Brain Tumor Patients- / S.Nakagawa et al. / p294～294
Workshop 268.Preoperative Irradiation for the Carcinoma of Periampullary Region / O.Ishikawa et al. / p294～294
Workshop 269.Diagnosis of Intrapancreatic Development of Pancreatic Head Cancer and Extended Radical Operation Combined with Operative Irradiation / A.Nakao et al. / p295～295
Workshop 270.Clinical Studies on Intraoperative Radiotherapy and Postoperative Conformation Radiotherapy Applied to Pancreatic Carcinoma / Y.Tanaka et al. / p295～295
Workshop 271.Hyperthermochemotherapy for Pancreatic Cancer / Y.Yamamoto et al. / p295～295
Workshop 272.Adriamycin,5-Fluorouracil,Mitomycin-C(AFM)Combination Regimen with Induced Hypertension Chemotherapy(IHC)in Advanced Pancreatic Carcinoma / M.Hoshi et al. / p296～296
Workshop 273.Short Ischemia of Tumor by Noradrenalin Administered into Tumor Feeding Arteries after Chemotherapy Improved Antitumor Effect on Pancreas Cancer / T.Sato et al. / p296～296
Workshop 274.Extended Operation for Cancer of the Pancreas with Reference to Factors Influencing Spread and Recurrence / T.Manabe et al. / p296～296
Workshop 275.Combined Modality Therapy for Advanced Pancreatic Cancer / N.Kuno et al. / p297～297
Workshop 276.A Combined Therapy with Hyperthermia and Radiation for Bone Metastasis from Renal Cell Carcinoma / S.Kanoh et al. / p297～297
Workshop 277.A Combined Treatment of 8 MHz RF-hyperthermia with/without Chemoembolization or Irradiation for advanced Renal Cancer / K.Nakaiima et al. / p297～297
Workshop 278.Minimal Surgical Intervention for Renal Cell Carcinoma(RCC)Invading into Inferior Vena Cava(IVC)--Use of Preoperative Chemoembolization and Artificial Vascular Patch / T.Kato et al. / p298～298
Workshop 279.A Comparison of Preoperative Embolization and Arterial Injection in Renal Cancer / T.Asahi et al. / p298～298
Workshop 280.Combination Therapy of Vinblastine and Nicardipine in Human Renal Cell Carcinoma / M.Masuda et al. / p298～298
Workshop 281.Adjuvant Therapy for Renal Cell Carcinoma before and after Nephrectomy / H.Nakazawa et al. / p299～299
Workshop 282.Immunotherapy for Renal Cell Carcinoma / T.Tsukarnoto et al. / p299～299
Workshop 283.Clinical Results of Human Interferon Gamma(S-6810)for Renal Cell Carcinoma / T.Machida et al. / p299～299
Workshop 284.Combination Chemotherapy for Advanced Renal Cell Carcinoma with Interferon and MVP Therapy (MTX,VBL and PEP) / Y.Satomi et al. / p300～300
Workshop 285.Immunotherapy by Administration of Autologous Lymphokine-Activated Killer Cells and Interleukin 2 for Renal Cancer / E.Nakano et al. / p300～300
Workshop 286.Extended Radical Nephrectomy for Renal Cell Carcinoma Extending into the Inferior Vena Cava / K.Okada et al. / p300～300
Workshop 287.Surgical Management of Renal Cancer with Vena Caval Involvement / S.Isaka et al. / p301～301
Workshop 288.The Removal of Renal Carcinoma Thrombus Extending into the Inferior Vena Cava / F.Kondo et al. / p301～301
Workshop 289.The Effect of Bismuth Subnitrate on Cisplatin Nephrotoxicity / J.Chen et al. / p301～301
Workshop 290.Significance of FOM and Evaluation of Renal Function on CDDP Therapy for Urothelial Cancer / S.Yogi et al. / p302～302
Workshop 291.The Modification of the Kinetics of Cisplatin with Hypertonic Saline and/or Fos-fomycin / M.Horiuchi et al. / p302～302
Workshop 292.Two Way Continuous Hyperthermic Peritoneal Perfusion Therapy Using High-dose CDDP and STS for Patients of Peritoneal Metastasis from Gastric Cancers / R.Miyata et al. / p302～302
Workshop 293.Combined Effect of Cis-diamminedichloroplatinum(CDDP) and Sodium Thiosulfate(STS)for Lung Cancer / A.Hirosawa et al. / p303～303
Workshop 294.Antiemetic Effect of High-Dose Metoclopramide(MCP)in Cisplatin Therapy / T.Yamada et al. / p303～303
Workshop 295.Anti-emetic Treatment with Metoclopramide and Other Drugs during CDDP Therapy / N.Kodama et al. / p303～303
Workshop 296.Antiemetic Efficacy of High-Dose Metoclopramide and Dexamethasone in Patients Receiving Cisplatin-Based Chemotherapy / T.Tamura et al. / p304～304
Workshop 297.A Randomized Crossover Comparison of the Antiemetic Activity of High-Dose Metoclopramide(MCP)and High-Dose MCP+Methylprednisolone(MP) against CDDP-Induced Emesis / K.Matsui et al. / p304～304
Workshop 298.A Pilot Study of Methylprednisolone for the Prevention of Cis-Diamminedichloro-platinum(II)-Induced Nausea and Vomiting / S.Ozono et al. / p304～304
Workshop 299.Scalp Hypothermia Combined with Tocopherol to Prevent Adriamycin-Induced Hairloss / Y.Mizoi et al. / p305～305
Workshop 300.Neo-Adjuvant Chemotherapy with UFT,Adriamycin and CoenzyrmeQ₁₀ / N.Hyo et al. / p305～305
Workshop 301.Not Received / /
Workshop 302.Recombinant Human Granulocyte Colony Stimulating Factor(Hu Re G-CSF) Induces Granulocytopoiesis in vivo / T.Okabe et al. / p305～305
Workshop 303.Clinical Study of Colony-Stimulating Factor from Human Urine (P-100) on the Granulocytopenia Induced by Chemotherapy for Malignant Tumors in Gynecology / K.Ueda et al. / p306～306
Workshop 304.Antibiotic Therapy in Cancer Patients with Granurocytopenia / M.Sano et al. / p306～306
Workshop 305.Simplified Sterile Isolator is Effective Prevention against Infection of Patients with Granulocytopenia / I.Adachi et al. / p306～306
Workshop 306. The Effect of Lithium Carbonate on Chemotherapy-Induced Myelosuppression / S.Kodama et al. / p307～307
Workshop 307.Primary Effect of PP Therapy(Including Intravenous and Arterial Injection) on Carcinoma of the Oral Cavity / I.Tohnai et al. / p307～307
Workshop 308.Prevention of Side Effect of Intra-arterial Infusion Therapy for Liver Cancer
By Monitering the Concentration of Anticancer Drugs / Y.Une et al. / p307～307
Workshop 309.Transcatheter Arterial Chemo-Embolization Therapy for Patients with Infantile Hepatoblastoma / T.Ichihara et al. / p308～308
Workshop 310.Supporting Therapy of Intra-arterial Chemotherapy in Advanced Breast Cancer / K.Asaishi et al. / p308～308
Workshop 311.Toxicity of Cisplatin,Adriamycin and Cyclophosphamide(CAP)Therapy / Y.Osuga et al. / p308～308
Workshop 312.Distant Metastases of Differentiated Thyroid Cancer / N.Kasai et al. / p309～309
Workshop 313.Study on Recurrent Cases of Five-year Survivors after Curative Resection of the Thoracic Esophagus / Y.Sekine et al. / p309～309
Workshop 314.Pathological Evaluation of the Patients with Poorly Differentiated Adenocarcinoma of the Stomach Who Died More Than 5 Years after Operation / H.Usuki et al. / p309～309
Workshop 315.The Study of the Cases That Died of the Late Recurrence of Gastric Carcinoma after Curative Resection / T.Tani et al. / p310～310
Workshop 316.Evaluation of Late Recurrent Cases of Gastric Cancer / T.Fukuda et al. / p310～310
Workshop 317.Study on the Cases with Late Onset of Recurrent Gastric Cancer / Y.Yamamura et al. / p310～310
Workshop 318.Studies on Gastric Cancer Patients Who Died of Recurrence More Than Five Years after Curative Resection / N.Saito et al. / p311～311
Workshop 319.Mode of Recurrence in Gastric Cancer Patients with More Than 5-year Disease-free Period
Change with Adjuvant Chemotherapy / M.Hiratsuka et al. / p311～311
Workshop 320.Survey on Recurrent Cancers of the Large Intestine--Focusing on Recurrence Cases after 5 Postoperative Years or More / M.Kiriyama et al. / p311～311
Workshop 321.Liver Metastases Occured More Than 5 Years after Radical Operation Report of 4 Patients / I.Ozawa et al. / p312～312
Workshop 322.Recurrence of Lung Cancer Five or More Years after Complete Pulmonary Resection / K.Kunishima et al. / p312～312
Workshop 323.Late Recurrences of Breast Cancer at Intervals of over Five Years after Mastectomy / S.Miura et al. / p312～312
Workshop 324.A Study on Cases of Breast Cancer Relapsing over 5 Years after Operation / S.Takashima et al. / p313～313
Workshop 325.Cases with Recurrence of Breast Cancer More Than Five Years after Surgery / H.Sasaki et al. / p313～313
Workshop 326.Late Recurrence of Uterine Cervical Carcinoma after Radical Hysterectomy / I.Shiozawa et al. / p313～313
Workshop 327.The Pathological Consideration about the Two Cases of Recurrent Uterine Cervical Carcinoma(CC)More Than 10 Years after Operation / A.Yamaga et al. / p314～314
Workshop 328.Clinical Evaluation of Cases of Metastatic Renal Cell Carcinoma Presenting after a Tumor-Free Interval of Greater Than Five Years Post Radical Nephrectomy / M.Fukuda et al. / p314～314
Workshop 329.Clinical Studies on Renal Cell Carcinoma Metastasized over Five Years after Ne-phrectomy / T.Onishi et al. / p314～314
Workshop 330.A Case of Renal Cell Carcinoma which Recurred in the Rest Kidney and Died of Cerebellar Hemangioblastoma
Hipple-Lindau Disease / S.Ichijo et al. / p315～315
Workshop 331.Long Term Prognosis after Total Cystectomy in Patients with Invasive Bladder Cancer / A Yamasaki et al. / p315～315
Workshop 332.A Case Report of Late Pulmonary Metastasis from Osteosarcoma / T.Yagi et al. / p315～315
Workshop 333.Late Recurrence of 3 Children with Cancer:The Problems of Postoperative Chemotherapy / K.Nagashima et al. / p316～316
Workshop 334.Pulmonary Metastasis Resected after Long Disease Free Intervals (More Than 5 Years) / N.Miyazawa et al. / p316～316
Workshop 335.Not Received / /
Workshop 336.The Clinical Pharmacokinetics of Etoposide in Patients with Gynecologic Malignancy / T.Kurose et al. / p316～316
Workshop 337.Clinical Efficacy of Etoposide(VP16-213)and MECA Therapy in Trophoblastic Disease / M.Maeda et al. / p317～317
Workshop 338.Clinical Evaluation of Etoposide and Cisplatin in Gestational Choriocarcinoma / K.Kanazawa et al. / p317～317
Workshop 339.Present Problems of Treatment for Choriocarcinoma Patients / T.Ishizuka et al. / p317～317
Workshop 340.Treatment for Choriocarcinoma Having a Long Latent Period / M.Takayama et al. / p318～318
Workshop 341.Treatment of Brain Tumor by Magnetic Induction Hyperthermia Using Ferromagnetic Implant with Low Curie Point--Experimental Study on Rat Brain Tumor Model / T.Tanaka et al. / p318～318
Workshop 342.Increasing Anticancer Effects of Charge-Changed Liposomes Including Various Drugs in vitro / K.Nishihara et al. / p318～318
Workshop 343.Pharmacokinetics and Toxicity of Intrathecal Administration of Recombinant Interleukin-2 / S.Miyatake et al. / p319～319
Workshop 344.Studies on Immunological Parameters during Interferon Therapy for Malignant Brain Tumors--Changes of T-cell Subsets by Method of Two-Color Analysis / M.Nagai et al. / p319～319
Workshop 345.The Interstitial Irradiation of Malignant Gliomas--After-loading Technique / S.Shibui et al. / p319～319
Workshop 346.Experience of 80 Cases of Brain Tumors Treated by Boron-neutron Capture Therapy / H.Hatanaka et al. / p320～320
Workshop 347.Not Received / /
Workshop 348.Surgical Guiding with Flow Cytometry(FCM)for Malignant Gliomas--Rapid Cell Cycle Analyses and General Application of FCM for Maignant Neo-plasms / H.Yamamoto et al. / p320～320
Workshop 349.Early Phase II Study of the Adoptive Immunotherapy of Patients with Meningeal Gliomatosis by LAK Cells / K.Shimizu et al. / p320～320
Workshop 350.Antitumor Efficacy of Recombinant Interferon-β Human Glioma / Y.Miyao et al. / p321～321
Workshop 351.Intentional Radiochemotherapy for Malignant Glioma Based on Experimental Analy-sis / M.Kitahara et al. / p321～321
Workshop 352.Effects of Intraarterial ACNU against Recurrent Malignant Gliomas Following Chemotherapy with Systemic Nitrosoureas / Y.Ushio et al. / p321～321
Workshop 353.Hypofractionation(5Gy Twice a Week)and/or Misonidazole in the Radiation Therapy of Glioblastoma / K.Hayakawa et al. / p322～322
Workshop 354.Intraoperative Radiotherapy and Brachytherapy for Glioblastoma / H.Tanaka et al. / p322～322
Workshop 355.Radiation Therapy for Retinoblastoma / I.Tsukiyama et al. / p322～322
Workshop 356.Proton Radiotherapy for Ocular Melanoma / S.Morita et al. / p323～323
Workshop 357.Animal Experiments of Lagendijk′s Microwave Applicator for Hyperthermic Treatment of the Eyeball / A.Kaneko et al. / p323～323
Postersession 1.Subpopulation of Lymphocytes Infiltrated in Cancer Tissues of Head and Neck Regions:Correlation of Subpopulation and Clinico-pathologic Findings / J.Hirota et al. / p324～324
Postersession 2.A Diagnostic Evaluation of Excisional Biopsy with Patients with T1N0 Carcinoma of the Tongue / H.Kasai et al. / p324～324
Postersession 3.Studies on Clinico-Pathological Malignancy of Tongue Cancer / H.Sunakawa et al. / p324～324
Postersession 4.Depth of Invasion of Carcinoma of the Tongue and Its Recurrence Factor / T.Kawaguchi et al. / p325～325
Postersession 5.Long Survivor after Radiotherapy of Tongue Carcinoma / T.Inoue et al. / p325～325
Postersession 6.Clinicopathological Study of 38 Autopsy Cases with Oral Malignant Tumor -1st Report Metastases- / K.Obata et al. / p325～325
Postersession 7.Study on Cellular Immunity in DMBA Induced Hamsters′Tongues Neo-plasia Forma-tion:Peritoneal Macrophage Funciton (Superoxide Production Ability) / Y.Shigeta et al. / p326～326
Postersession 8.A Study on Subsets of Peripheral Blood Lymphocytes and Various Skin Testes in Course of Treatment of Oral Cancer Patients / K.Ryoke et al. / p326～326
Postersession 9.Effect of Combination Immunotherapy of OK-432 and SPG on Peripheral Blood Monouclear Leucocytes of Cancer Patients / Y.Umezu et al. / p326～326
Postersession 10.Application of Flow Cytometry for Oral Solid Tumors / R.B.Chen et al. / p327～327
Postersession 11.Analysis of Lymphocytes Infiltrated in Cancer Tissues of Patients during Radiation Therapy by the Method of Monoclonal Antibodies of Lyrnpho Cyte Subsets / F.Hamada et al. / p327～327
Postersession 12.Radiation-induced Cancer of the Head and Neck / K.Umatani et al. / p327～327
Postersession 13.Clinical Survey of Radiation Induced Cancer / K.Ichikawa et al. / p328～328
Postersession 14.Radiotherapy of Head and Neck Tumors with Combined Use of Misonidazole and Polychemotherapy / H.Asakura et al. / p328～328
Postersession 15.An Evaluation of Multidisciplinary Treatment of Carcinoma of the Maxillary Antrum in Head and Neck Surgery / S.Matsuura et al. / p328～328
Postersession 16.Application of the Prosthetic Splint for Reduction of Side Effects during Radiotherapy to an Advanced Aged Patient with Oral Cancers / T.Kawamura et al. / p329～329
Postersession 17.Radiotherapy in Aged Laryngeal Cancer Patients / K.Sakaino et al. / p329～329
Postersession 18.Treatment Results of Radiation-Chemotherapy for Patients of Carcinoma of the Lower Gum with Bone Invasion / Y.Matayoshi et al. / p329～329
Postersession 19.Primary Clearance for Head and Neck Cancer by Combined Radiation with or without Chemotherapy Comparison with Predicting Probability from Multivariate Model by RTOG / Y.Ohizumi et al. / p330～330
Postersession 20.Experimental Study on UFT with Concomitant Radiotherapy / J.Tanaka et al. / p330～330
Postersession 21.UFT for Head and Neck Cancers:Its Tissue Concentrations and Effect of Lymphocyte Subpopulations / M.Tachibana et al. / p330～330
Postersession 22.Administration to Head and Neck Malignant Tumors Concentrations in Serum and Tumor / K.Tsuchikawa et al. / p331～331
Postersession 23.In vitro Chemosensitivity of Head and Neck Cancers Evaluated by SDI(Succinate Dehydrogenase Inhibition)Test / K.Tomita et al. / p331～331
Postersession 24.Combination Chemotherapy with CDDP in Non-Squamous Cell Carcinoma of the Head and Neck / T.Furusaka et al. / p331～331
Postersession 25.Mechanism of Synergism in Combination of 4′-O-Tetrahydropyranyl-Adriamycin,Cisplatin and Peplomycin (Flow Cytometry) / H.Hosoda et al. / p332～332
Postersession 26.Combination Chemotherapy with Adriamycins,Cisplatin and Peplomycin for Head and Neck Cancer / Y.Inuyama et al. / p332～332
Postersession 27.Alternating Combination Chemotherapy with Cisplatin,Peplomycin,Methotrexate,Mitomycin C and Cisplatin,Peplomycin,Adriamycin,Cyclophosphamide for Advanced Head and Neck Carcinoma / T.Aoyama et al. / p332～332
Postersession 28.An Evaluation of Results of Neo-adjuvant Chemotherapy for Maxillary Cancer / M.Igarashi et al. / p333～333
Postersession 29.Local Cancer Therapy by Means of Direct Current / M.Yokoyama et al. / p333～333
Postersession 30.Interstitial Hyperthermia Using Nd-YAG Laser Irradiation / I.Moriyama et al. / p333～333
Postersession 31.Experiences of Primary Reconstruction of Oral Cavity and Mesopharynx by Use of Free Forearm Flap / S.Hanazawa et al. / p334～334
Postersession 32.Reconstruction Method of Alveolar Ridge with Porous Hydroxyapatite Blocks and Forearm Free Flap after Mandibulectomy for Commando Operation of Oral Cancer / S.Okabe et al. / p334～334
Postersession 33.Relation between Clinico-Pathological Diagnosis and Prognosis in Carcinoma of the Buccal Mucosa and the Lip / A.Miyakawa et al. / p334～334
Postersession 34.Treatment Results in Carcinoma of the Mouth Floor at Gunma Cancer Center / B.Satake et al. / p335～335
Postersession 35.Treatment Results of Major Salivary Gland Cancer / R.Shimizu et al. / p335～335
Postersession 36.Clinical Analysis and Cause of Death of Supraglottic Cancer / H.Miyahara et al. / p335～335
Postersession 37.Treatment and Result of Hypopharyngeal Cancer Comparision between before and after Introduction of One Stage Reconstruction / S.Takeoda et al. / p336～336
Postersession 38.Surgical and Non-Surgical Treatment Results for Carcinoma with Intracranial Invasion from Extracranial Lesions / T.Murakami et al. / p336～336
Postersession 39.Not Received / /
Postersession 40.Multidisciplinary Treatment of Malignant Melanoma of the Mouth A Review of Two Cases / H.Tanabe et al. / p336～336
Postersession 41.The Clinical Study of Malignant Melanoma during the Last Ten Years in Kagoshima University Hospital Evaluation of Low-Phenylalanine,Low-Tyrosine Diet Therapy / R.Kiyota et al. / p337～337
Postersession 43.A Study on 3 Long Term Survival Cases of Head and Neck Cancer with Chemotherapy Alone / T.Takaoka et al. / p337～337
Postersession 44.Malignant Fibrous Histiocytoma of the Head and Neck An Analysis of Three Cases / M.Akune et al. / p337～337
Postersession 45.Familial Occurrences of Oral Cancer / H.Hara et al. / p338～338
Postersession 46.A Clinical Study of the Minor Salivary Gland Carcinoma of the Oropharynx / W.Ohyama et al. / p338～338
Postersession 47.Multidisciplinary Treatment of Maxillary Sinus Cancer / T.Kato et al. / p338～338
Postersession 48.Urological Significance of PSTI Measurement / Y.Ohishi et al. / p339～339
Postersession 49.Clinical Evaluation of Serum Placental Leucine Aminopeptidase Activity in Renal Cell Carcinoma / M.Kuriyama et al. / p339～339
Postersession 51.A Clinical Study of CA 19-9 for Patients with Urological Disease / T.Tanaka et al. / p340～340
Postersession 52.Changes in the Level of Polyamines after Operation / T. Koide et al. / p340～340
Postersession 53.Clinical Study of Serum Phosphofrucrokinase in Urological Cancers / Y.Takahashi et al. / p340～340
Postersession 54.Clinical Study of Serological Parameter in Testicular Tumor / K.Yoshida et al. / p341～341
Postersession 55.Clinical Study of Testicular Tumor--Detection of hCG-Concentrated Urine in Patients with Seminoma / T.Suaawara et al. / p341～341
Postersession 56.NSE(Neuron Specific Enolase)in Testicular Cancer / A.Itani et al. / p341～341
Postersession 57.Seminoma with Slightly Elevated HCG / I.Takahashi et al. / p342～342
Postersession 58.Histological Study of Subrenal Capsule Assay(SRCA)in Human Testiculer Tumor / T.Wada et al. / p342～342
Postersession 59.Sensitivity Test of Anticancer Agents Using Human Urological Cancer Xenografted in Nude Mice / M.Honda et al. / p342～342
Postersession 60.Therapeutic Effects of Anticancer Drugs to Human Wilms′Tumor Transplanted into Nude Mice:Histopathological Studies / S.Yamada et al. / p343～343
Postersession 61.Clinical Observation of Testicular Tumors--Clinical Efficacy of Combined Chemotherapy for Disseminated Testicular Tumors / H.Sudoko et al. / p343～343
Postersession 62.Paraplegia due to Metastasis of Testicular Tumors / A.Furuhata et al. / p343～343
Postersession 63.A Case of Testicular Tumor-Stage IIIc / A.Suzuki et al. / p344～344
Postersession 64.Fertility after Treatment for Patients with Testicular Cancer / T.Miyauchi et al. / p344～344
Postersession 65.Clinicopathological Evaluation of 103 Cases of Testicular Tumor / K.Nomata et al. / p344～344
Postersession 66.Thymidine Kinase and Its Isozyme Activities in Human Thyroid Gland / S.Murakami et al. / p345～345
Postersession 67.Clinical Evaluation of Pancreas Cancer-Associated Antigen in Patients with Medullary Thyroid Carcinoma / K.Ueno et al. / p345～345
Postersession 68.Effect of Parathyroid Autotransplantation on Plasma PTH Level in Thyroid Carcinoma Surgery / H.Sugiura et al. / p345～345
Postersession 69.Treatment of Thyroid Adenocarcinoma with Natural Human Interferon(IFN)-γ / N.Aoki et al. / p346～346
Postersession 70.Cisplatin and Adriamycin Therapy for Anaplastic Thyroid Carcinoma / T.Tabei et al. / p346～346
Postersession 71.Bone Metastasis of Thyroid Carcinoma / A.Tsuchiya et al. / p346～346
Postersession 72.An Evaluation of Recurrent Nerve Palsy due to Radical Surgery for Thyroid Cancer / S.Makino et al. / p347～347
Postersession 73.Results of Total Thyroidectomy and Extensive Lymph Node Dissection in Patients with Papillary Thyroid Carcinoma / S.Mizuno et al. / p347～347
Postersession 74.Bone Metabolism in Breast Cancer Patients / S.Takeuchi et al. / p347～347
Postersession 75.Clinical Features and Treatment of Hypercalcemia Associate with Breast Cancer / H.Tashiro et al. / p348～348
Postersession 76.Study of Patients with Bone Recurrent Breast Cancer / M.Kimura et al. / p348～348
Postersession 77.Not Received / /
Postersession 78.Evaluation of Tumor-Markers(CEA,AFP,Ferritin,TPA and CA15-3) in the Serum of Patients with Recurrent Breast Carcinoma / H.Fukushima et al. / p348～348
Postersession 79.Clinical Evaluation of a New Breast Tumor Associated Antigen CA15-3,for Breast Cancer Patients / S.Shimizu et al. / p349～349
Postersession 80.Tumor Markers in Breast Cancer--A Comparative Study of CA15-3 and CEA in Clinical Use / H.Sonoo et al. / p349～349
Postersession 81.Clinical Study of CA15-3 in Human Breast Cancer / M.Nihei et al. / p349～349
Postersession 82.Clinical Evaluation of Cancer Antigen 15-3(CA15-3)as Tumor Marker for Defined Breast Cancer / I.Yokoyama et al. / p350～350
Postersession 83.Studies on Estrogen Receptor in Human Breast Cancer by Specific Monoclonal Antibody / S.Tsuchiya et al. / p350～350
Postersession 84.Evaluation of Breast Cancer-Specific Anti-Tumor Immunity by"IL-2 Enhanced MLTR" / N.Kan et al. / p350～350
Postersession 85.Diagnosis for Breast Disease by Pharmacological-thermography with Angiotensin II(Second Report) / Y.Hamada et al. / p351～351
Postersession 86.Low Field Magnetic Resonance Imaging of the Breast / K.Kanasugi et al. / p351～351
Postersession 87.Current Status of Diagnosis of Breast Cancer with Palpation,Mammography,Ultra-sound / K.Yoshida et al. / p351～351
Postersession 88.A Study on the Diagnosis and Biopsy for Breast Cancer / T.Asagoe et al. / p352～352
Postersession 89.Diagnostic Significance of CEA Measurement in Nipple Discharge for the Detection of Non-Palpable Breast Cancer / E.Yayoi et al. / p352～352
Postersession 90.MRI in Urological Cancer / K.Nishimura et al. / p352～352
Postersession 91.Pre-Operative Diagnosis for the Tumor Thrombus of Renal Cell Carcinoma Extended into Inferior Vena Cava / T.Shimazui et al. / p353～353
Postersession 92.Fine Needle Aspiration Biopsy of the Kidney and Adrenal Gland / K.Ono et al. / p353～353
Postersession 93.Effect of AS Vaccinia Virus for Advanced Cancer / S.Arakawa et al. / p353～353
Postersession 94.Interferon Therapy for Renal Cell Carcinoma / M.Suzuki et al. / p354～354
Postersession 95.A New Trial of Combined Chemotherapy with Tegafur,Tamoxifen,Adriamycin and Methotrexate for Advanced Clear Cell Carcinoma / T.Wada et al. / p354～354
Postersession 96.Examination of the Plasma Filtrated by Plasmapheresis in Terminal Stage Patients with Urogenital Malignant Tumors / Y.Ogawa et al. / p354～354
Postersession 97.Efficacy of Nephrectomy for Renal Cell Carcinoma with Pulmonary Metastases / S.Ichijo et al. / p355～355
Postersession 98.The Results of Radical Nephrectomy for Renal Cell Carcinoma / Y.Nishio et al. / p355～355
Postersession 99.Recurrence of Renal Cell Carcinoma after Radical Nephrectomy / T.Igarashi et al. / p355～355
Postersession 100.Clinical Study of Renal Cell Carcinoma / S.Miyahara et al. / p356～356
Postersession 101.Prognostic Evaluation in Renal Cell Carcinoma / M.Suzuki et al. / p356～356
Postersession 102.Clinicopathogical Factors which Affect the Survival Rates of Renal Cell Carcinoma / M.Hoshino et al. / p356～356
Postersession 103.Clinicostatistical Observation on Renal Cell Carcinoma / K.Yoshikawa et al. / p357～357
Postersession 104.Immunity of Regional Lymph Node Lymphocytes in Patients with Breast Cancer A Study of Lymphocyte Blastogenesis with PHA and PNP(Purine Nucleoside Phosphorylase)Activity / T.Takahashi et al. / p357～357
Postersession 105.Immune Complex and Extracorporeal Plasma Perfusion over Protein A Immobilized in Collodion Charcoal / T.Nagai et al. / p357～357
Postersession 106.Effect of Local Treatment with OK-432 and PSK in Recurrent Breast Cancers / M.Okazaki et al. / p358～358
Postersession 107.Effects of Estrogen and Prolactin on DNA-synthesizing Enzyme Activities in NMU-induced Rat Mammary Tumor / N.Kasahara et al. / p358～358
Postersession 108.Effect of Chemo-endocrine Therapy on DMBA-induced Mammary Carcinoma:Nuclear DNA Analysis / N.Matsunami et al. / p358～358
Postersession 109.Aminoglutethimide Treatment for Advanced Breast Cancer / F.Takaeko et al. / p359～359
Postersession 110.Prognositic Value of Hormone Receptor in Breast Cancer / H.Yamamoto et al. / p359～359
Postersession 111.Clinical Evaluation of Intra-arterial Infusion of Adriamycin (ADR) for Locally Advanced Breast Cancer(The 3rd Report) / T.Morimoto et al. / p359～359
Postersession 112.Study on Effect of Adriamycin on Advanced or Recurrent Breast Cancer(The 4th Report) / M.Izuo et al. / p360～360
Postersession 113.CAP Therapy (CPA,ADR,CDDP)for Advanced or Recurrent Breast Cancer--Especially for the Lymphangitic Type of Lung Metastasis / T.Yokoe et al. / p360～360
Postersession 114.Change of Concanavalin A-induced Suppressor Cell Activity in Breast Cancer Patients Treated with CMF Chemotherapy / N.Hagino et al. / p360～360
Postersession 115.The Effect of Anticancer Drugs on the Growth of Hormone Dependent Breast Cancer Cell Line, ZR-75-1 II.Anticancer Drug and Estradiol / K.Akamatsu et al. / p361～361
Postersession 116.Evaluation of the ATF [Low Dose Adriamycin (A)+Tamoxifen(T)+Tegafur(F)] Therapy as Adjuvant Chemotherapy for Breast Cancer / Y.Nishizawa et al. / p361～361
Postersession 117.Eight Year Follow-up of Adjuvant Endocrine Therapy with Mepitiostane for Operable Breast Cancer / Y.Nomura et al. / p361～361
Postersession 118.Establishment of Monoclonal Antibody (KEN-3) against Human Mammary Cell Line(HBC-4W) / Y.Kiyozuka et al. / p362～362
Postersession 119.ClinicalTrial of Bestrabucil(KM2210)in Patients with Breast Cancer / T.Yamakawa et al. / p362～362
Postersession 120.Clinical Evaluation of a New Oral Anti-Cancer Agent, Bestrabucil(KM2210),on Recurrent Breast Carcinoma / Y.Yamada et al. / p362～362
Postersession 121.Phase II Study of Bestrabucil(KM2210) on Advanced and Recurrent Breast Cancer / O.Abe et al. / p363～363
Postersession 122.Therapeutic Results of Recurrent Mammary Carcinoma with the Use of Bestrabucil(KM2210) / T.Ueda et al. / p363～363
Postersession 123.Target Oriented Anticancer Agent Bestrabucil for Long Term Treatment for Recur-rent and Far-advanced Breast Cancers / Z.Yamazaki et al. / p363～363
Postersession 124.A Trial of Recombinant Human Tumor Necrosis Factor Administration for Cancerous Pleural Effusion / K.Morimoto et al. / p364～364
Postersession 125.Internal Mammary Involvement and Estimated 5 Years Survival Rate on 120 Patients Who Underwent the Radical Mastectomy with Intrapleural en bloc Resection of Internal Mammary Lymph Node by Sternal Splitting / K.Tajiri et al. / p364～364
Postersession 126.Surgical Treatment for Local Recurrence of the Breast Carcinoma / H.Komoriyama et al. / p364～364
Postersession 127.Studies on the Quality of Life after Mastectomy / Y.Takatsuka et al. / p365～365
Postersession 128.Retrospective Analysis of the Treatment of Stage IIIb Breast Cancer / K.Namba et al. / p365～365
Postersession 129.PVB Chemotherapy on Endodermal Sinus Tumor of the Ovary / Y.Kawai et al. / p365～365
Postersession 130.Results of Cisplatin and Adriamycin Treatment on Malignant Ovarian Tumor and Correlation between Patients Status and Su-PS Skin Test Reaction / T.Kubota et al. / p366～366
Postersession 131.CDDP-ACR-CPA Combination Chemotherapy for Malignant Ovarian Tumors / N.Ushiki et al. / p366～366
Postersession 132.Effect of Fosfomycin (FOM) for CAP Ohemotherapy in Ovarian Cancer / A.Ikegawa et al. / p366～366
Postersession 133.The Protective Effect of Fosfomycin on the Nephrotoxicity in CAP Therapy for Ovarian Cancer / K.Miyasaka et al. / p367～367
Postersession 134.Clinical Study on Effectiveness of FCAP Chemotherapy for Ovarian Malignant Tumor / Y.Misawa et al. / p367～367
Postersession 135.Clinical Evaluation of Maintenance Chemotherapy with UFT for Ovarian Cancer / K.Kamioka et al. / p367～367
Postersession 136.Interactions of Hyperthermia and Drugs,(Adriamycin, Mitomycin C, Bleomycin,Cisplatinum) in a Human Ovarian Tumor Heterotransplanted in Nude Mice / T.Sagawa et al. / p368～368
Postersession 137.The Treatment of Krukenberg Tumors,Primarily by FAP Therapy / M.Tamura et al. / p368～368
Postersession 138.Clinical Characteristics of Serous Cystadenocarcinoma and Mucinous Cystadenocar-cinoma of the Ovary / I.Fujimoto et al. / p368～368
Postersession 139.Role of Laparoscopy for Early Detection of Recurrence in Cases of Post Operative Ovarian Cancer / T.Shinozuka et al. / p369～369
Postersession 140.Laparoscopic Follow-up of Patients with Ovarian Cancer / H.Yokota et al. / p369～369
Postersession 141.Clinical Study of Ovarian Cancer / T.Nakano et al. / p369～369
Postersession 142.A Report of Hypomagnecemia as a Result of Combination Chemotherapy Including CDDP / M.Yamanaka et al. / p370～370
Postersession 143.Acute Leukemia Sustained after Maintenance Chemotherapy for Ovarian Cancer--Report of a Case / T.Shimoda et al. / p370～370
Postersession 144.A Case of Droperidol Anesthesia in CAP Chemotherapy / Y.Sugiyama et al. / p370～370
Postersession 145.A Case of Ovarian Endometrioid Adenocarcinoma Being Refractory to Modern Combination Chemotherapy / T.Morita et al. / p371～371
Postersession 146.Cell Distribution of Each Cell Cycle Phase in Uterine Cancer / T.Sugishita et al. / p371～371
Postersession 147.Distribution of DNA Synthesizing Cells and Labelling Index of Cervical Cancers with Enzyme Antibody Method Using Anti-BrdU Antibody / T.Muroya et al. / p371～371
Postersession 148.Endometrial Adenocarcinoma and Paraaortic Lymph Node Metastasis / K.Matsukuma et al. / p372～372
Postersession 149.Pulmonary Metastasis of Carcinoma of the Cervix:A Clinocopathologic Study of 50 Patients / M.Imachi et al. / p372～372
Postersession 150.Bone Metastasis of the Carcinoma of the Uterine Cervix / K.Nakayama et al. / p372～372
Postersession 151.Bony Metastasis from Cervix Cancer / T.Matsuyama et al. / p373～373
Postersession 152.Clinico-pathologic Features of Bone Metastasis of Cancer of Uterine Cervix and Modality of Its Treatment / T.Higuchi et al. / p373～373
Postersession 153.A Clinicopathological Study on Bone Metastases of Cervical Carcinoma at Kure National Hospital / T.Nobunaga et al. / p373～373
Postersession 154.Prognosis and Therapeutic Results of Brain Metastasis in Trophoblastic Disease / K.isaka et al. / p374～374
Postersession 155.Pancreatic Secretory Trypsin Inhibitor (PSTI) in Gynecologic Cancer / K.Hirota et al. / p374～374
Postersession 156.Significance of TA-4 in the Detection of Recurrence in Cervical Squamous Cell Carcinoma / H.Morioka et al. / p374～374
Postersession 157.Prediction of the Recurrence of Cervical Uterine Cancer by Serum TA-4 Monitoring / T.Oishi et al. / p375～375
Postersession 158.Positive Ratios of Tumor Markers in Pre-Treatment Patients with Gynecological Malignant Tumor / Y.Yamane et al. / p375～375
Postersession 159.Studies on Multiple Tumor Markers in Patients with Carcinoma of the Uterine Cervix / M.Tanaka et al. / p375～375
Postersession 160.Relationship between DNA Content and Cellular Content of SCC-Ag, TPA and CEA in AMCC-1 Cultured Cells / H.Yabushita et al. / p376～376
Postersession 161.Change of Peripheral T Lymphocyte Subsets in Gynecologic Cancer Patients / R.Hayase et al. / p376～376
Postersession 162.Clinical Assesment of the Measurement of hCG Fragment in the Trophoblastic Disease / S.Imamura et al. / p376～376
Postersession 163.An Immunohistochemical Approach for the Radiosensitivity in Carcinoma of the Uterine Cervix / K.Fukuda et al. / p377～377
Postersession 164.Usefullness of Immunohistochemical Combination Assay for Differential Diagnosis of Cervical or Endometrial Adenocarcinoma / Y.Okamura et al. / p377～377
Postersession 165.Response to Interleukin-2 and Its Receptor in Peripheral Blood Lymphocytes of Patients with Gynecologic Malignancies / Y.Kikuchi et al. / p377～377
Postersession 166.Detection of Vascular Invasion on the Operative Specimen of Gastric Cancers--Evaluation of Three Staining Methods / M.Tsugita et al. / p378～378
Postersession 167.Distribution of Fibronectin in Gastric Cancers at Primary and Metastatic Sites / T.Kawafuchi et al. / p378～378
Postersession 168.A Clinicopathological Study of Gastric Cancer with Peritoneal Disseminated Metas-tasis / Y.Kato et al. / p378～378
Postersession 169.Not Received / /
Postersession 170.Tumor Markers of Gastric Cancer / H.Iwai et al. / p379～379
Postersession 171.Significance of Tumor Marker Measurement in Discovery of Recurrence of Stomach Cancer after Radical Operation / M.Hiramatsu et al. / p379～379
Postersession 172.Correlation between Tumor Associated Antigens in Gastric Cancer Tissue and Prognosis / T.Kamata et al. / p379～379
Postersession 173.Evaluation of Serum Neuron-Specific Enolase as a Tumor Marker for Gastrointestinal Carcinoma / N.Nakagawa et al. / p380～380
Postersession 174.A Study of Carbohydrate Antigen 19-9 in Tissue with Carcinomas of Human Digestive Organs / N.Tanimoto et al. / p380～380
Postersession 175.Localization of CEA and CA19-9 in Atypical Epithelial Lesiones and Well-Differentiated Early Cancer of the Stomach / K.Kohfuji et al. / p380～380
Postersession 176.Carcinoembryonic Antigen of Gastric Cancer Patients / N.Shimizu et al. / p381～381
Postersession 177.The of Biological Response Modifiers(BRM)on Carcinoembryonic Antigen(CEA)Level in the Serum of Gastric Cancer Patients / T.Saeki et al. / p381～381
Postersession 178.Changes of Killer Activity and Humoral Antibody in Cancer Patient,with Special Reference to Relationship to Stage of Diseases / H.Ubukata et al. / p381～381
Postersession 179.Immunohistochemical Study with Double Staining Method on Regional Lymph Nodes of Gastric Cancer / S.Chohno et al. / p382～382
Postersession 180.A Study of Endoscopic Ultrasonography on the Early Gastric Cancer--Determination of Depth of Cancer Invasion / M.Okubo et al. / p382～382
Postersession 181.A Study on TNF Production of Cultured Monocytes of Human Peripheral Blood in vitro--The Effect of OK-432 Injection for the TNF Production / T.Yamasaki et al. / p382～382
Postersession 182.The Effectiveness of Freeze and Dried Tumor Cells as Adding Antigen to Lymphocytes Culture / H.Watanabe et al. / p383～383
Postersession 183.Effects of Levamisole (LMS) on Immunity of Regional Nodes / S.Owada et al. / p383～383
Postersession 184.Effect of Intraperitoneal Injection of OK-432 on Patients with Carcinomatous Peritonitis--Study on Cytology and Sialic Acid in Ascites / I.Watanabe et al. / p383～383
Postersession 185.Clinico-pathological Characteristics on Medullary Carcinoma with Markedly Lymphoid Infiltration (MCLI) of Stomach and Clinical Application of Intratumoural Injection of OK432 / M.Mai et al. / p384～384
Postersession 186.Randomized Controlled Study of Post Operative Gastric Cancer Chemotherapy--Comparison with Mifurol and Tegafur / H.Sato et al. / p384～384
Postersession 187.A Prospective Randomized Trial Comparing AF versus FAM in Advanced Gastric Cancer--The Second Study of a Cooperative Study Group / T. Yokomori et al. / p384～384
Postersession 188.Effectiveness of Postoperative Immunochemotherapy on stage IV Gastric Cancer / Y.Akamo et al. / p385～385
Postersession 189.A Sequential Study of Adjuvant Immunochemotherapy for Gastric Cancer after Gastrectomy / K.Yoshinaka et al. / p385～385
Postersession 190.A Multi-institutional Study on Postoperative Adjuvant Immunochemotherapy for Gastric Cancer / T.Nakajima et al. / p385～385
Postersession 191.A Study of Surgical Adjuvant Immunochemotherapy for Gastric Cancer The specific Study (1) [II]-Three-year-Survival- / Y.Nakanishi et al. / p386～386
Postersession 192.Protocol Practice Supported by a Computer-Based Medical-Record System / K Akazawa et al. / p386～386
Postersession 193.Intra-Arterial Infusion Therapy with Angiotensin-II for Patients with Advanced and Recurrent Cancer of Stomach / N.Takahashi et al. / p386～386
Postersession 194.Intraaortic Infusion Therapy with Sequential Methotrexate (MTX) and 5-FU for Advanced Gastric Carcinoma / M.Kitamura et al. / p387～387
Postersession 195.Constant Intra-arterial Infusion Chemotherapy for the Patients with Gastric Cancer Who Had Intraabdominal Metastases / M.Sato et al. / p387～387
Postersession 196.Experimental Studies of Endoscopic Local Hyperthermia with Low Power Nd-YAG Laser Irradiation by Using Frosted Probe / J.Aoki et al. / p387～387
Postersession 197.Treatment of Advanced Gastric Cancer with Local Radiofrequency Hyperthermia and Continuous Hyperthermic Peritoneal Perfusion / Y.Yonemura et al. / p388～388
Postersession 198.Not Received / /
Postersession 199.The Effect of Preoperative Irradiation Therapy in Advanced Stomach Cancer with Special Reference to Histopathological Changes of Metastatic Lymph Nodes / Y.Goto et al. / p388～388
Postersession 200.Intraoperative Local Injection of Fine Particles of Activated Charcoal Applied for Lymph Nodes Dissection of Gastrointestinal Cancers / T.Yamaguchi et al. / p388～388
Postersession 201.Evaluation of Gastric Cancer Resected Palliatively because of Liver Metastasis / T.Nakadate et al. / p389～389
Postersession 202.Investigation of the Gastric Cancer with Bone Metastasis / H.Horichi et al. / p389～389
Postersession 203.Study on Gastric Squamous Cell and Adenosquamous Cell Carcinomas / H.Ishibashi et al. / p389～389
Postersession 204.Not Received / /
Postersession 205.Tamoxifen-induced Growth Inhibition to Cultured Human Gastric Cancer Cells and Tamoxifen Binding Fraction in Cancer Cell / H.Ohkura et al. / p390～390
Postersession 206.The Antitumor Effects of Human Fibroblast Interferon(IFN-β)and 5-FU on Human Gastric Cancers Xenografts in Nude Mice / K.Mitsuda et al. / p390～390
Postersession 207.Chemotherapy Responsiveness of Human Gastric Cancer Implanted in Subrenal Capsules of Nude Mice / M.Yamauchi et al. / p390～390
Postersession 208.Effectiveness of the Adriamycin-Almineum(ADR-Al)Complex upon the Human Gastric Cancer Transplanted to Nude Mice / M.Tanaka et al. / p391～391
Postersession 209.Changes of Plasma Concentration of 5-Fluorouracil in Long Term Oral Administration / M.Fujii et al. / p391～391
Postersession 210.Study on the Correlation between Tissue Uptakes of Tegafur and Prognosis / S.Arima et al. / p391～391
Postersession 211.Anticancer Drug Distribution to Lymph and Blood in Adjuvant Chemotherapy after Surgery for Gastric Carcinoma--A Study with Combined Preparation of 1-(2-Tetrahydrofuryl)-5-Fluorouracil and Uracil / H.Hanaue et al. / p392～392
Postersession 212.Evaluation of Continuous Drip Infusion of Tegaful with Intravenous Hyperalimenta-tion before and after Surgery in Gastric Cancer Patients / A.Hizuta et al. / p392～392
Postersession 213.UFT+MMC and UFT+ACNU Therapy on Advanced Gastric Cancer / T.Sasai et al. / p392～392
Postersession 214.Clinical Usefulness of UFT-M-O Therapy for Advanced Gastro-intestinal Cancer / S.Misawa et al. / p393～393
Postersession 215.The Combination Chemotherapy of Epirubicin,Mitomycin C and 5-Fluorouracil(FEM) against Inoperable Gastric Cancer / T.Kimura et al. / p393～393
Postersession 216.The Effects of PMU Therapy for Advanced Gastric Cancer / N.Matsuki et al. / p393～393
Postersession 217.Combination Chemotherapy of UFT(F),Etopside(E)and CDDP(P)in Advanced Gastric Cancer / M.Hayakawa et al. / p394～394
Postersession 218.Effects of Cis-dichlorodiammineplatinum(CDDP)in Advanced Gastro-intestinal Tract Cancer--Application for Pre-and Post-operative Chemotherapy / S.Saji et al. / p394～394
Postersession 219.Effects of Cis-platinum(CDDP)for Recurrent Cancer of the Stomach and the Colon / A.Kadowaki et al. / p394～394
Postersession 220.Methotrexate(MTX)and 5-Fluorouracil(5FU with Leucovorin(LV)Therapy for Advanced Gastric Cancer / I.Sugiura et al. / p395～395
Postersession 221.Chemosensitive Oriented Therapy(COT)for Unresectable Gastric Cancer with Peritoneal Disseminations / Y.Hiramoto et al. / p395～395
Postersession 222.Evaluation of Antitumor Efficacy by Polyamine Antimetabolites in Combination with DNA Attacking Anticancer Drugs / R.D. Shrestha et al. / p395～395
Postersession 223.Pharmakokinetics of Cisplatin in Patients with Chronic Renal Failure / M.Miyakawa et al. / p396～396
Postersession 224.Study on a Survival Time of Gastric Cancer Patients Using Multivariate Analyses / M.Sawai et al. / p396～396
Postersession 225.Prognostic Factors of Primary Gastric Cancer,Univariate and Multivariate Analyses of 4,734 Resected Cases / K.Maruyama et al. / p396～396
Postersession 226.Quality of Life after Surgical Treatment of Gastric Cancer / T.Kuroda et al. / p397～397
Postersession 227.Multidisciplinary Treatment for a Case of Recurrent Peritoneal Dissemination with Massive Omental Tumor / H.Ueda et al. / p397～397
Postersession 228.Cronkhite-Canada Syndrome Associated with Cancer / A.Goto et al. / p397～397
Postersession 229.A Study of Gastric Cancer with Multiple Primary Carcinoma(MPC) / H.Motohashi et al. / p398～398
Postersession 230.The Case Report in Which IgE Was Seen to be Absorbed in the Gastric Cancerous Tissue by Immuno-peroxidase Method / T.Fujii et al. / p398～398
Postersession 231.Specific of Monoclonal Antibody,A7,against Human Colorectal Cancers and Possibil-ity of Missile Therapy / H.Suzuyama et al. / p398～398
Postersession 232.Tissue Localization of Endogenous Sex Hormones in Colorectal Cancer Tissues / Y.Uehara et al. / p399～399
Postersession 233.Chemosensitivity of Human Colorectal Cancer Xenografted In Nude Mice / K.Yamada et al. / p399～399
Postersession 234.Effect of a Combination of UFT and MMC(UFT-M)on Colonic Cancer Xenotrans-planted in Nude Mice / Y.Takahashi et al. / p399～399
Postersession 235.Anti-Cancer Treatment with Prostaglandin Synthetase Inhibitor Indomethacin / M.Takahashi et al. / p400～400
Postersession 236.Adjuvant Immuno-chemotherapy of Colorectal Cancer with MMC,Tegafur and PSK / T.Tominaga et al. / p400～400
Postersession 237.Multidisciplinary Treatment for Advanced Colorectal Cancer with Long Term Continuous i.v. Infusion of 5FU / H.Kida et al. / p400～400
Postersession 238.A Randomized Controlled Study on Adjuvant Chemotherapy with Mitomycin C and HCFU in Noncuratively Resected Colorectal Cancer Patients / M.Niimoto et al. / p401～401
Postersession 239.Transcatheter Arterial Chemoembolization for the Alimentary Tract--A Trial in the Colorectal Cancers / K.Mieno et al. / p401～401
Postersession 240.PDT in Recurrent Rectal Carcinoma Using a Pulsed Gold Vapour Laser / K.Kato et al. / p401～401
Postersession 241.Clinical and Pathological Studies of Cases Undergoing Curative Operation for Rectal Cancer (Comparison between Poor Prognostic Group and Long Survival Group) / Y.Kuzawa et al. / p402～402
Postersession 242.A Young Case with Colon Cancer Detected at Emergency Operation and Study of Young Cases with Colon Cancer / T.Yamanaka et al. / p402～402
Postersession 243.Comparison Study of Histological Classification of Non-Hodgkin′s Lymphoma / M.Kita et al. / p402～402
Postersession 244.Immunosuppressive Acidic Protein(IAP)in the Patients with Hematological Malig-nancy / S.Hayashi et al. / p403～403
Postersession 245.Thymidylate Synthetase and Thymidine Kinase Activities in Bone Marrow Cells of Leukemias / H.Kudo et al. / p403～403
Postersession 246.Radiotherapy for Adult T-cell Leukemia / Y.Baba et al. / p403～403
Postersession 247.Treatment Results from Radiation Therapy to Non-Hodgkin Lymphomas in Head and Neck Region / K.Sakata et al. / p404～404
Postersession 248.Drug Sensitivity Test on Leukemic Blast Progenitors / Y.Asano et al. / p404～404
Postersession 249.Cisplatin-ACNU Therapy for Non-Hodgkin′s Lymphoma / Y.Araki et al. / p404～404
Postersession 250.A New Combination Chemotherapy for Non-Hodgkin's Lymphoma / C.Konda et al. / p405～405
Postersession 251.Not Received / /
Postersession 252.Effects of Adriamycin on Lymphocyte Subsets and Lymphocyte Functions in vitro / Y.Suzuki et al. / p405～405
Postersession 253.The Combination of Aclarubicin (ACR),Vincristine(V),Cyclophosphamide(C),and Prednisolone(P),(ACR-VCP)in the Treatment of Multiple Myeloma / K.Izumi et al. / p405～405
Postersession 254.Stage I and II Non-Hodgikin′s Lymphomas of the Head and Neck:The Working Formulation is of Value for Predicting Outhome / N.Shigematsu et al. / p406～406
Postersession 255.Clinical Trial of MCNU Tablets on Hematological Malignancies / I.Tanaka et al. / p406～406
Postersession 256.Clinical Effects of TA-077 in Non-Hodgkin's Lymphomas / T.Kobayashi et al. / p406～406
Postersession 257.Clinical Trial of SM-108 on the Myeloproliferative Syndromes / M.Nishikawa et al. / p407～407
Postersession 258.Not Received / /
Postersession 259.Treatment of Disseminated Intravascular Coagulation(DIC)with Gabexate Mesilate(FOY)in Malignant Disease / H.Wada et al. / p407～407
Postersession 260.Mechanism of Brain Metastasis
Correlation with Cerebrovascular Disease / Y.Tokuriki et al. / p407～407
Postersession 261.Basic Research of Treatment with Protease Inhibitor for Meningeal Gliomatosis / C.Obonai et al. / p408～408
Postersession 262.Long-Term Effects of Cranial Irradiation and Chemotherapy on Hemocirculation and Metabolism of Brain Tissue in Patients with Brain Tumors / K.Mineura et al. / p408～408
Postersession 263.Radiation Therapy of Pontine Glioma / Y.Aoki et al. / p408～408
Postersession 264.Radiotherapy for Pineal Region Tumors / S.Nishino et al. / p409～409
Postersession 265.Proton Radiation Therapy for Brain Tumors / Y.Yoshii et al. / p409～409
Postersession 266.Analysis of Relapse after Postoperative Irradiation at Astrocytoma Grade II-IV / K.Nishikawa et al. / p409～409
Postersession 267.Results of Radiation Therapy for Brain Metastases / M.Kataoka et al. / p410～410
Postersession 268.Effect of ACNU on Cell Proliferation of Experimental Brain Tumor / S.Izumoto et al. / p410～410
Postersession 269.Inhibitory Effect of A¹²-prostaglandin J₂ on Rat Brain Tumor and Rat NK Activity / H.Matsuura et al. / p410～410
Postersession 270.Chemotherapy with Nitrosoureas and UFT against Malignant Brain Tumors / H.Okamoto et al. / p411～411
Postersession 271.Adjuvant Chemotherapy for Brain Tumors / M.Ito et al. / p411～411
Postersession 272.Investigation for Clinical Trial of Brain Heating by Magnator NK / M.Ohta et al. / p411～411
Postersession 273.Anti-tumor Effect of Human Recombinant TNF(PT-050)on a Tumor Line of Human AFP Producing Immature Teratoma / K.Kurisu et al. / p412～412
Postersession 274.Induction of LAK Cells from Splenocytes or Thymocytes in Normal and 9L-Glioma Bearing Rat / H.Imaya et al. / p412～412
Postersession 275.Not Received / /
Postersession 276.Cbservations on the Local Administration of Autologous Lymphokine Activated Killer Cells and Recombinant Interleukin-2 to Patients with Malignant Gliomas / S.Yoshida et al. / p412～412
Postersession 277.Not Received / /
Postersession 278.Sister Chromatid Exchange as a Measure of Tumor Cell and Normal Cell(Lymphocyte)Sensitivities to ACNU / S.Kobayashi et al. / p413～413
Postersession 279.Malignant Lymphoma Initially Involved of the Brain (Experience of 10 cases) / Y.Tamaki et al. / p413～413
Postersession 280.Treatment Results of Cerebral Differentiated Gliomas in Adults / M.Matsutani et al. / p413～413
Postersession 281.Observations of Adenocarcinoma of the Prostate According to the Criteria of Gleason′s Score : Clinicopathological Assesment of 93 Cases / H.Kusuyama et al. / p414～414
Postersession 282.Clinicopathological Study of Prostatic Cancer(Part 3) / Y.Furukawa et al. / p414～414
Postersession 283.A Comparative Study with the Cases of Transitional Cell Carcinoma of the Prostate and the Cases with Prostatic Involvement of Transitional Cell Carcinoma of the Urinary Bladder / K.Takai et al. / p414～414
Postersession 284.Clinical Evaluation of Measurement of Multiple Markers in Prostate Cancer / I.Shinoda et al. / p415～415
Postersession 285.Usefulness of PAP,Y-Sm and PA as Markers for Prostatic Cancer / T.Akagi et al. / p415～415
Postersession 286.Relationship between Relapse and Tumor Markers in Prostatic Cancer / H.Fuse et al. / p415～415
Postersession 287.Intraoperative Radiotherapy for Carcinoma of the Prostate / S.Kojima et al. / p416～416
Postersession 288.Proton Therapy for Genitourinary Cancer / S.Nemoto et al. / p416～416
Postersession 289.Radiation Therapy for Localized Prostatic Cancer / H.Suto et al. / p416～416
Postersession 290.Pelvic Lymphadenectomy before Radiotherapy for Prostatic Carcinoma / T.Takeda et al. / p417～417
Postersession 291.Chemotherapy of Antiandorogenic Therapy Resistant Prostate Cancer / M.Takeda et al. / p417～417
Postersession 292.Treatment of stage D Prostatic Cancer Patients with Hormones in Combination with Cyclophosphamide / I.Nakamura et al. / p417～417
Postersession 293.Cheme-hormonal Therapy in the Untreated Patients with Poorly Differentiated Adenocarcinoma of the Prostate at stage D / J.Yoshimoto et al. / p418～418
Postersession 294.Attempt of Preoperative Stage Down Chemotherapy against Prostatic Cancer / M.Yuasa et al. / p418～418
Postersession 295.Etoposide Therapy for the Prostatic Cancer / M.Maruoka et al. / p418～418
Postersession 296.Experience with an LH-RH Agonist in the Treatment of Prostatic Cancer--Monitoring of Tumor Markers(γ-Seminoprotein,Prostate Specific Antigen,Pros-tatic Acid Phosphatase) / Y.Tada et al. / p419～419
Postersession 297.Clinical Response and Safety of Buserelin(LH-RH Agonist)Treatment in Prostatic Cancer / Y.Ishii et al. / p419～419
Postersession 298.Clinical Efficacy of LHRH Analogue(Buserelin)in Advanced Carcinoma of Prostate / K.Suzuki et al. / p419～419
Postersession 299.Treatment of Prostatic Cancer with LH-RH Analog / J.Shimazaki et al. / p420～420
Postersession 300.Effects of Gonadotropin-Releasing Hormone Analogues(LH.RH Analogues) on the Untreated Prostatic Carcinoma / H.Akaza et al. / p420～420
Postersession 301.Clinical Significance of Radical Prostatectomy and Nerve Sparing Radical Pros-tatectomy / K.Okada et al. / p420～420
Postersession 302.A Mass Screening of Prostatic Cancer in Nagasaki City / Y.Minami et al. / p421～421
Postersession 303.Factors Affecting Survival in the Patients with Prostatic Carcinoma / M.Hiramori et al. / p421～421
Postersession 304.Surgical Treatment of Plantar Palmer Subungual Melanoma / T.Tomita et al. / p421～421
Postersession 305.Treatment of Malignant Melanoma with HuIFN-β Given Preoperatively by Local Injection / A.Yamamoto et al. / p422～422
Postersession 306.Clinical Evaluation of Radioisotopes(⁶⁷Ga-citrate,⁹⁹mTc,²⁰¹Tl-chloride) in the Diagnosis of Soft Part Tumors / Y.Beppu et al. / p422～422
Postersession 307.Evaluation of Chemotherapy of Malignant Soft Part Tumors by Nuclear Magnetic Resonance / Y.Shimomura et al. / p422～422
Postersession 308.Adjuvant Chemotherapy for Patients with Soft Tissue Sarcomas of Extremities / Y.Ogihara et al. / p423～423
Postersession 309.Preoperative Intra-arterial Infusion Chemotherapy for Soft Tissue Sarcomas / T.Ueda et al. / p423～423
Postersession 310.4 Cases of Malignant Lymphomas Manifested Surface Tumor / M.Ishikura et al. / p423～423
Postersession 311.Infantile Fibrosarcoma / Y.Hatae et al. / p424～424
Postersession 312.Clinical Behavior and Follow-up Results of 28 Patients with Neurosarcoma / I.Sugiura et al. / p424～424
Postersession 313.Prognostic Factor of Soft Tissue Sarcomas / H.Bun et al. / p424～424
Postersession 314.S-100 Protein Immunostaining in the Differential Diagnosis of Bone Tumors and Tumorous Conditions / K.Okajima et al. / p425～425
Postersession 315.Not Received / /
Postersession 316.Immunomodulating Effect of Gamma Interferon on Human Osteosarcoma Cell Lines / J.Toguchida et al. / p425～425
Postersession 317.The Anti-Tumor Effect of Vitamin D3 on Dunn Osteosarcoma / K.Hara et al. / p425～425
Postersession 318.DNA-RNA Cytofluorometric Analysis of the Effect of Adriamycin, Cis-Diammine-dichloroplatinum(II)and Methotrexate on Dunn Osteosarcoma in vivo / S.Nakamura et al. / p426～426
Postersession 319.Evaluation of Efficacy of Chemotherapeutic Agents on Transplantable Spontaneous and 4-HAQO Induced Osteosarcoma in Rats / Y.Miyauchi et al. / p426～426
Postersession 320.Cytofluorometric Evaluation of the Effect of the Preoperative Chemotherapy on the Malignant Bone and Soft Tissue Tumors / K.Kusuzaki et al. / p426～426
Postersession 321.The Sensitivity Test of Anti-cancer Agent for Malignant Bone and Soft Tissue Sarcomas / H.Fukushima et al. / p427～427
Postersession 322.Tc Bone Scintigram of Axial Skeleton in Cancer Patients, Referring to the Initial Diagnosis to Recongition of Abnormal Uptake, and Prognosis / S.Morishita et al. / p427～427
Postersession 323.Staging of Metastatic Bone Disease / K.Yamashita et al. / p427～427
Postersession 324.Natural History of Mucosal Hyperplasia and Dysplasia which Obtained from the Spe-cimen of Multiple Cold-cup Biopsy in Normal-looking Mucosa with Superficial Bladder Cancer / K.Uchida et al. / p428～428
Postersession 325.Relationship between Endoscopic Nontumorous Mucosal Changes and Flat Path-ological Lesions in Patients with Urinary Bladder Carcinoma / M.Wajiki et al. / p428～428
Postersession 326.A Study on Measurement of Urinary Fibronectin / S.Nakatsuka et al. / p428～428
Postersession 327.Evaluation on Responder's Check to Non-specific Immunotherapy in Cancer-Bearing Hosts / Y.Nakagami et al. / p429～429
Postersession 328.Therapeutic Intravesical Instillation of BCG in the Management of Bladder Tumors / S.Jitsukawa et al. / p429～429
Postersession 329.Intravesical BCG Therapy for Bladder Tumors / M.Murayama et al. / p429～429
Postersession 330.Intravesical Bacillus Galmette-Guerin in the Treatment of Recurrent Superficial Bladder Tumors / M.Nakano et al. / p430～430
Postersession 331.Histological Changes in Bacillus Calmette-Guerin Immunotherapy for Bladder Cancer and Normal Epithelia / T.Kogawa et al. / p430～430
Postersession 332.Experience of Intralesional Injection of Recobinant IL-2 in Bladder Cancer / T.Fujioka et al. / p430～430
Postersession 333.Intravesical Administration of GKT-β for Bladder Cancer / Y.Matsumura et al. / p431～431
Postersession 334.The Effect of LC-9018 on Human Bladder Cancer / E.Karasawa et al. / p431～431
Postersession 335. Tissue Concentration and Infiltration to Tumor Tissue of Adriamycin and (2")R-4′- O-Tetrahydrophyranyladriamycin in Intravesical Instillation for Rat Bladder Tumors by BBN / H. Masuda et al. / p431～431
Postersession 336. Effect of Continuous Intravesical Instillation of Mitomycin-C on the Development of N-butyl-N-4-hydroxybutyl-nitrosamine (BBN) Induced Rat Bladder Tumor / S. Kawano et al. / p432～432
Postersession 337. Intravesical Instillation Therapy of Peplomycin and Cytosine Arabinoside for Bladder Tumor Comparison with Mitomycin C or Adriamycin / N. Kinoshita et al. / p432～432
Postersession 338. Sequential Instillation Therapy with Mitomycin-C and Adriamycin for Superficial Bladder Cancer / I. Fukui et al. / p432～432
Postersession 339. The Serum Concentration of Adriamycin Intravesically Instillated Immediately after the TUR-Bt / T. Akiya et al. / p433～433
Postersession 340. Comparison of the Various Immunosuppressive Drugs in Subrenal Capsular (SRC) Assay--Using FANFT Induced Mouse Bladder Tumor (MBT-2) / H. Mitsui et al. / p433～433
Postersession 341. Preliminary Study of Flow Cytometric DNA/Bromodeoxyuridine (Brdu) Analysis with the Aim of Application to Drug-Sensitivity Test / T. Shimabukuro et al. / p433～433
Postersession 342. Study of the Change in Chemosensitivity during Chemotherapy for Uroepithelial Cancers / H. Kanamaru et al. / p434～434
Postersession 343. Enzymuria Following CDDP Administration : Difference in Increase Pattern of Urinary Activities between NAG and γ-GTP / T. Takahashi et al. / p434～434
Postersession 344. Platinum Distribution and Concentration in the Human Tissue after Administration of Cisplatin / T. Tochigi et al. / p434～434
Postersession 345. Blood and Tissue Concentration of HCFU and 5-FU in Oral Administration of HCFU to Bladder Tumor Patients / M. Ohinata et al. / p435～435
Postersession 346. The Combination Chemotherapy with Cyclophosphamide, Adriamycin, and Cis-plati-num in Advanced Urothelial Tumor / Y. Tanaka et al. / p435～435
Postersession 347. Chemotherapy of Advanced Urinary Bladder Cancer / Y. Kubota et al. / p435～435
Postersession 348. Not Received / /
Postersession 349. Prognosis after Surgical Treatment of Pulmonary Metastases of Osteosarcomas / H. Yoshikawa et al. / p436～436
Postersession 350. Surgical Treatment of Bone Tumor Metastasized in the Lung--Indication and Mode of Operation / A. Koyama et al. / p436～435
Postersession 351. The Treatment of Metaststic Carcinoma of Extremities Using External Fixation / Y. Hamada et al. / p436～436
Postersession 352. 2 Cases of Total Femur Replacement for Cancer Patients / K. Hirohata et al. / p437～437
Postersession 353. Surgical Treatment for Metastatic Bone Tumors of the Lower Extremity / K. Suzuki et al. / p437～437
Postersession 354. Surgical Treatment for Metastatic Bone Tumor of Limb and Pelvis / A. Suda et al. / p437～437
Postersession 355. Treatment of the Metastatic Carcinoma of the Spine / K. Mochizuki et al. / p438～438
Postersession 356. Possible Use of Boron Neutron Capture Therapy in Limb Preservation in Dogs with Osteosarcoma / A. Takeuchi et al. / p438～438
Postersession 357. Total Femur Replacement for Osteosarcoma of the Femur A Case Report / N. Miyake et al. / p438～438
Postersession 358. Tumor Prosthesis after Wide Resection for Osteosarcoma / A. Uchida et al. / p439～439
Postersession 359. Limb Salvage Procedures for Malignant Bone Tumors of the Extremities, with Special Reference of the Verious Reconstructive Procedures for the Defect of Bone / T. Morita et al. / p439～439
Postersession 360. Reconstruction of Malignant Bone Tumor by Composite Graft of Biomaterial / K. Shinjo et al. / p439～439
Postersession 361. Chondrosarcoma of the Ribs : Treatment of 5 Cases / H. Yahagi et al. / p440～440
Postersession 362. Giant Cell Tumor of Bone A Clinicopathologic and Cytophotometric Study of 28 Cases / M. Ushijima et al. / p440～440
Postersession 363. Clinical Study of Sacrococcygeal Chordoma : A Report of twelve Cases / M. Yamanashi et al. / p440～440
Postersession 364. Radioimmunodetection of Neuroblastoma with Anti-neuroblastoma Monoclonal Antibody / T. Etoh et al. / p441～441
Postersession 365. Verapamil Enhancement of Antitumor Effect of Cis-diamminedichloroplatinum (II) in Nude Mouse-grown Human Neuroblastoma / H. Ikeda et al. / p441～441
Postersession 366. Chemotherapy for Advanceed Neuroblastoma / K. Shimizu et al. / p441～441
Postersession 367. Aggressive Treatment of Neuroblastoma in Advanced Stage / T. Takeda et al. / p442～442
Postersession 368. An Evaluation of Chemotherapy by Means of Balloon Occluded Arterial Infusion (BOAI) to Advanced Gynecological Cancer / H. Takahashi et al. / p442～442
Postersession 369. Thermotherapy for the Gynecological Malignant Tumors, Particularly Combined Effects with Radio-or Chemotherapy / Y. Kobashi et al. / p442～442
Postersession 370. A Case of Hyperthermia (Inductive Aperture-Type Applicator) for Skin Metastasis of Endometrial Cancer / S. Kijima et al. / p443～443
Postersession 371. An Evaluation of Operative Cases of Endometrial Cancer / M. Ikeuchi et al. / p443～443
Postersession 372. Clinical and Histological Study on the Tissue Repair after Conization / M. Nagahara et al. / p443～443
Postersession 373. Conization by CO2 Laser in the Uterine Cervix / Y. Okuma et al. / p444～444
Postersession 374. Carbon Dioxide Laser Conization for Cervical Intraepithelial Neoplasia / M. Moriyama et al. / p444～444
Postersession 375. Long-term Follow-up Studies on the Treatment of CIN by CO₂ Laser Vaporization / K. Yonagida et al. / p444～444
Postersession 376. Urological Complications Following Radical and Extended Hysterectomy for Uterine Cancer / M. Matsuzawa et al. / p445～445
Postersession 377. In Radical Hysterectomy Employing Ultrasonic Aspiration Technique, the Pelvic Nerve was Well Preserved / I. Matsunaga et al. / p445～445
Postersession 378. The Role of Thoracotomy for Metastatic Choriocarcinoma / M. Matsumura et al. / p445～445
Postersession 379. Clinico-pathological Analysis of stage IIIa Carcinoma of the Cervixuteri / A. Takano et al. / p446～446
Postersession 380. Clinico-pathological Study on Endometrial Carcinoma--The Factors Influencing the Prognosis / T. Akahori et al. / p446～446
Postersession 381. Clinicopathologic Study on Carcinoma of Uterine Body / K. Shiromizu et al. / p446～446
Postersession 382. 12 Cases with Primary Carcinoma of the Fallopian Tube / Y. Nakai et al. / p447～447
Postersession 383. Pelvic Exenteration : 5 Cases Experience / S. Hino et al. / p447～447
Postersession 384. A Case Report of Uterine Carcinosarcoma with Alfa-Fetoprotein (AFP) Production / K. Shigemasa et al. / p447～447
Postersession 385. Remission of Cerebral Metastasis of Choriocarcinoma Followed by Normal Pregnancy and Delivery / H. Yokota et al. / p448～448
Postersession 386. Studies on Late Recurrence of the Carcinoma of Uterin Cervix in Osaka National Hospital / T. Shibamoto et al. / p448～448
Postersession 387. A Preliminary Result of Radiation plus Hydroxyurea for Glassy Cell Carcinoma of the Uterine Cervix / D. Hori et al. / p448～448
Postersession 388. Chemotherapy for Squamous Cell Carcinoma of the Uterine Cervix A Study of in vivo Chemosensitivity Test in Nude Mice / M. Kawabata et al. / p449～449
Postersession 389. Response Indicator of Chemo-endocrine Therapy for Endometrial Cancer by Colony-forming Assay / J. Fujimoto et al. / p449～449
Postersession 390. The Determination of Thymidylate Tynthetase Inhibition for Testing Fluoro- pyrimidines / K. Sakakibara et al. / p449～449
Postersession 391. High Dose Chemotherapy for Gynecological Malignancy in A Bioclean Room / S. Matsuura et al. / p450～450
Postersession 392. The Effect of the Combination Chemotherapy with CDDP, Vinblastin and Pe- pleomycin on the Advanced or Recurrenced Gynecological Malignancies / Y. Onishi et al. / p450～450
Postersession 393. Experimental Studies for the Antitumor Effect of Oral Antitumor Agents on Gyne- cological Malignant Tumors / I. Sekiguchi et al. / p450～450
Postersession 394. Importance of Bestatin Therapy for Trophoblastic Disease (T. B. D) / A. Yamamoto et al. / p451～451
Postersession 395. Multimodal Treatment of Advanced Gynecological Cancers Including 4'-O-Tetrahy- dropyranyl-Adriamycin (THP-ADM) Chemotherapy / M. Hiroo et al. / p451～451
Postersession 396. Evaluation of Oral-adjuvant Chemotherapy for Post-operative Uterine Cervical Cancer and It′s Estimated Prognosis Curve / S. Okamura et al. / p451～451
Postersession 397. Study of Postoperative Therapy for Carcinoma of the Cervix (Comparison between BM, MOP Therapy and External Radiation) / K. Yoshida et al. / p452～452
Postersession 398. Pharmacologic and Therapic Studies of Continuous Subcutanuous Infusion of Pe- plomycin in Patients with Cancer of the Cervix Uteri / H. Asai et al. / p452～452
Postersession 399. Combination Chemotherapy with Cisplatin, Doxorubicin and Cyclophosphamide (CAP) for Recurrent Endometrial Cancer / S. Baba et al. / p452～452
Postersession 400. Intraarterial Chemotherapy with Cis-platinum and Adriamycin in Advanced Car-cinoma of the Uterine Cervix / T. Tsujii et al. / p453～453
Postersession 401. Evaluation of Antitumor Effect of Cisplatin to Carcinoma of the Uterine Cervix / O. Nakamoto et al. / p453～453
Postersession 402. Intra-arterial Infusion of Cisplatin for Stage III and IV Cervical Cancer / K. Miyazaki et al. / p453～453
Postersession 403. Selective Intra-arterial Administration of High Dose of CDDP in Combination Plasmapheresis / I. Tateyama et al. / p454～454
Postersession 404. A Study on Blood Flow with a Intraarterial Digital Subtraction Angiographic Method in Hypertension Chemotherapy Induced by Angiotensin II for Advanced Uterine Cervical Cancer / O. Iwanari et al. / p454～454
Postersession 405. Not Received / /
Postersession 406. Intra-Arterial Infusion Chemotherapy with Adriamycin for the Treatment of Uterin Cervical Cancer / H. Taniguchi et al. / p454～454
Postersession 407. Treatment of Advanced or Recurrent Uterine Cervical Cancer with Balloon Occlude Arterial Infusion / M. Kawabata et al. / p455～455
Postersession 408. Preoperative Evaluation of Localy Recurrent Uterine Cervical Cancer / K. Inafuku et al. / p455～455
Postersession 409. Significance of a CT SCAN after the Cure of a Gynecological Malignant Tumor (Especially on the Early Diagnosis of Lymphonodal Recurrence) / M. Tsuruoka et al. / p455～455
Postersession 410. Approach to the Fine Angioarchitecture of the Uterine Cervical Adenocarcinoma 3rd Report: Adenoma Maligunum and Poorly Differrentiated Adenocarcinoma / K. Yamashita et al. / p456～456
Postersession 411. Cytologic Study on Endocervical Lesions Using " Cytobrush " / T. Hasegawa et al. / p456～456
Postersession 412. Asymptomatic Endometrial Cancer at Cancer Institute Hospital / K. Yamauchi et al. / p456～456
Postersession 413. Screening Method to Detect Early Carcinoma of the Endometrium / T. Jobo et al. / p457～457
Postersession 414. Hysteroscopic Observation of Precancerous Lesions and Early Cancers of Endometrium / E. Takashima et al. / p457～457
Postersession 415. Correlation of Dose-volume Curve and Late Complication of the Rectum in the Uterine Cervix / J. Mizoe et al. / p457～457
Postersession 416. Conformation Radiotherapy for the Intrapelvic Lesions / T. Shimizu et al. / p458～458
Postersession 417. Radiotherapy with Interstitial Implantation for Female Pelvic Tumors / A. Takamura et al. / p458～458
Postersession 418. Radio-thermo Therapy against Radioresistant Factors of Uterine Adenocarcinoma / H. Sasaki et al. / p458～458
Postersession 419. Radiotherapy for Uterine Cervical Cancer / N. Mitsuhashi et al. / p459～459
Postersession 420. A Study of Proton Beam Therapy for the Patients with Carcinoma of Uterine Cervix / M. Kaneko et al. / p459～459
Postersession 421. Not Received / /
Postersession 422. Protection of Parametritis Using Latamoxef after Lymphnodectomy / A. Yakabe et al. / p459～459
Postersession 423. Clinical Evaluation of Immunopotentiators for Advanced Cervical Cancer--Study on Cases of stage III Cervical Caner with Radical Surgery after Preoperative Irradiation / K. Hasegawa et al. / p460～460
Postersession 424. γ-Interferon Treatment on Cervical Intraepithelial Neoplasia / T. Iwasaka et al. / p460～460
Postersession 425. Investigation of Antitumor Activity and Prognosis in Patients with Cervical Carcinoma Administered BRM (Biological Response Modifier) Preoperatively / K. Wakida et al. / p460～460
Postersession 426. Effect of Recombinant Interleukin 2 on in vitro Autologous Tumor Cell Killing Activity of Gynecological Cancer Patients / Y. Kanaoka et al. / p461～461
Postersession 427. Evaluation of Prostaglandin Inhibitor in the Cancer Immunotherapy of OK-432 / Y. Ohshika et al. / p461～461
Postersession 428. Not Received / /
Postersession 429. Correlation of Cytological Grading and Pattern Grading with Prognosis of Ovarian Malignancies / M. Nakayama et al. / p461～461
Postersession 430. Activity of Glycoprotein Galactosyltransferase (GP.GT) in Serum of Cases of Ovarian Malignancy / Y. Okano et al. / p462～462
Postersession 431. Clinical Significance of Combination Assay with Tumor Marker in Ovarian Cancer / Y.Negishi it al / p462～462
Postersession 432. Basic and Clinical Studies of Tumor Marker CA15-3 in Obstetric and Gynecologic Field / S. Yamauchi et al. / p462～462
Postersession 433. Monitoring of Human Ovarian Carcinoma by Combination of Multiple Serum Tumor Markers / T. Kita et al. / p463～463
Postersession 434. Studies on Various Markers for the Precognition of the Recurrence of Ovarian Cancers / M. Nakayama et al. / p463～463
Postersession 435. CA19-9 and CEA in Ovarian Epithelial Tumors--Immunohistochemical Localization and Serum Levels / Y. Iwaoki et al. / p463～463
Postersession 436. Role of CA 125 in Patients with Ovarian Cancer--Usefulness in Periodical Monitoring / M. Kawai et al. / p464～464
Postersession 437. Placental Proteins 5, 10 and 11 (PP₅,₁₀ and ₁₁)--Their Serum Values during Pregnancy and Possible Clinical Application for Tumor Markers / N. Inaba et al. / p464～464
Postersession 438. Expression of Tumor-associated Antigens in a Case of Mixed Germ Cell Tumor / M. Hayashi et al. / p464～464
Postersession 439. The Distribution of LPA (Limulus Polyhemus Agglutinin) Receptors on the Cell Membrane of Peripheral Lymphocytes Associated with Cancer Patients / E. Soh (R. H. Tzeng) et al. / p465～465
Postersession 440. Administration Route and Timing of an Immunoactivating Agent for Ovarian Cancer / T. Noda et al. / p465～465
Postersession 441. The Relation between the Emesis and the Peripheral Plasma Prostaglandins during CAP Chemotherapy and Antiemetic Effect of Hydrocortisone / M. Ohwada et al. / p465～465
Postersession 442. Anti-cancer Effects and Side Effects Following Intraperitoneal (IP) Administration of Mitomycin C (MMC) / Y. Ino et al. / p466～466
Postersession 443. Mass Washing-off Therapy of Mitomycin C in the Peritoneal Cavity during the Operation of Ovarian Cancer / M. Sugase et al. / p466～466
Postersession 444. Not Received / /
Postersession 445. The Effects of Cis-Platin (CDDP) Combined Chemotherapy on Gonadal Function in Gynecological Malignancies / S. Shibata et al. / p466～466
Postersession 446. Intraperitoneal (Ip) High-dose-Cisplatinum (CDDP) Chemotherapy in Patients with Ovarian Cancer -Report IV Study of 33 Cases Treated with CDDP-Ip- / Y. Ninomiya et al. / p467～467
Postersession 447. Clinical Results of Intraperitoneal (Ip) Cisplatin (CDDP) and Systemic CAP Therapy / H. Kusanishi et al. / p467～467
Postersession 448. Comparative Studies of Genital Organ Tissue Concentrations, Plasma Concentrations, and Urinary Excretions of Platin between Intra-arterial and Intra-venous Injection of CDDP in Rabbits / S. Matsumoto et al. / p467～467
Postersession 449. Not Received / /
Postersession 450. The Evaluation of the Effects of Immunosuppresive Agents on Subrenal Capsule (SRC) Assay for Chemosensitivity Test / J. Haneda et al. / p468～468
Postersession 451. Determination of Tumor Chemosensitivity by Percentage Inhibition of DNA/Protein in Subrenal Capsule Assay / M. Nishiyama et al. / p468～468
Postersession 452. The Usefullness of Digital Image Processing by Computer in Subrenal Capusle Assay (SRCA) / H. Iwagaki et al. / p468～468
Postersession 453. Assay-Clinical Correlation in Subrenal Capsule Assay(Second Report) / T. Sasaki et al. / p469～469
Postersession 454. The Effects of 5-FU Derivatives on the Growth of Human Cancers Transplanted in Nude Mice / S. Imai et al. / p469～469
Postersession 455. The Growth Inhibitory/Cytotoxic Effects of Recombinant Human Tumor Necrosis Factor (rH-TNF) and/or Recombinant Human Interferon (rH-IFN) α, β, γ on Human Lung Cancer Cell Lines / W. S. Hong et al. / p469～469
Postersession 456. Intra-Arterial Long Term Infusion Chemotherapy via Transverse Cervical Artery for Intra-Abdominal Malignancies / I. Yokoyama et al. / p470～470
Postersession 457. Clinical Efficacy of Intra-arterial Continuous Infusion for Advanced Cancers of the Digestive System in the End Stage / H. Yamamoto et al. / p470～470
Postersession 458. Induced Hypertension Chemotherapy (IHC) Combined with Intraarterial Chemo-therapy for Advanced Gastric and Colorectal Carcinoma / M. Ueno et al. / p470～470
Postersession 459. Not Received / /
Postersession 460. Clinical Investigation of Transcatheter Arterial Embolization to the Patient with Recurrent and/or Advanced Pelvic Cancer / Y. Harima et al. / p471～471
Postersession 461. The Synergistic Effect of Human Recombinant TNF in Combination with Various Anticancer Drugs was Examined in vitro and in vivo / N. Yamauchi et al. / p471～471
Postersession 462. Clinical Trials (Early Phase II Study) on Malignant Human Tumors Using OH-1 Preparation Drived from BALL-1 Cell Line / S. Fuchimoto et al. / p471～471
Postersession 463. Cardiotoxicity of Mitoxantrone / K. Okuma et al. / p472～472
Postersession 464. Not Received / /
Postersession 465. Phase 1 Study of Carboplatin / K. Kimura et al. / p472～472
Postersession 466. A Case with a Carcinoma in the Lower Abdomen Treated Successfully with Oral Administration of Bestrabucil / S. Tsujitani et al. / p472～472
Postersession 467. A Case Report of Microangiopathic Hemolytic Anemia (MAHA) and Renal Failure after Mitomycin C and Futraful / M. Sagawa et al. / p473～473
Postersession 468. Assessment of the Diagnostic Value of Immunoscintigraphy with Labelled Monoclonal Antibodies (Anti CEA F (ab′)₂ and 19-9 F (ab′)₂) / T. Takahashi et al. / p473～473
Postersession 469. Effect of Hypoxic Cell Radiosensitizers on Murine Tumor / H. Fukuda et al. / p473～473
Postersession 470. Radiosencitization Using Perfluorochemicals and Angiotensin II / K. Harima et al. / p474～474
Postersession 471. Clinical Experience of High Dose Rate Remote Afterloading Interstitial Irradiation / K. Miura et al. / p474～474
Postersession 472. Ir-192 Brachytherapy by Afterloading Technique / Y. Akine et al. / p474～474
Postersession 473. Study on Irradiation Synchronized with Respiratory Motion / K. Ohara et al. / p475～475
Postersession 474. Intraoperative Radiotherapy for Cancers of the Biliary System and Pancreas / T. Yasunaga et al. / p475～475
Postersession 475. The Analysis of Cancer Patients Treated with Intraoperative Radiotherapy (IOR) / T. Inomata et al. / p475～475
Postersession 476. Tumor Cell Transplantation and Injection of Interferon as Modifying Factors of the Sensitivity of Mice to Systemic Hyperthermia / W. Nakamura et al. / p476～476
Postersession 477. Effect of Hyperthermia upon Mononuclear Cell Infiltration into Tumor Tissue--Analysis Using Monoclonal Antibodies / O. Kamiike et al. / p476～476
Postersession 478. Experimental Study of Direct Current Treatment Using Vascular Catheterization Technique(2)Usefulness of Ag-AgCl Electrode / T. Manabe et al. / p476～476
Postersession 479. Hyperthermia to the Patient with Adenocarcinoma / K. Yamamoto et al. / p477～477
Postersession 480. Local Response of Hyperthermia for Deep Seated Tumors / Y. Kajiura et al. / p477～477
Postersession 481. Multidisciplinary Treatment of Advanced Cancer Utilizing Local Hyperthermia,Implantable Catheter System for Intraarterial Anticancer Drug Infusion and Charcoal Hemoperfusion / T. Agishi et al. / p477～477
Postersession 482. Antitumor Activity of Systemically Administered Temperature-sensitive Liposomes Containing Adriamycin (TS-Lip-ADM) with Local Hyperthermia / T. Takahashi et al. / p478～478
Postersession 483. Clinical Trials of RF-Hyperthermotherapy for the Patients with Far-advanced Cancer of Digestive Organs / S. Sawai et al. / p478～478
Postersession 484. Temperature Distribution during Hyperthermia--Comparison of Calculated Values with Measured Temperatures / T. Nakajima et al. / p478～478
Postersession 485. Not Received / /
Postersession 486. Total Body Hyperthermia against advanced Cancer with Peritoneal Metastasis / N. Kato et al. / p479～479
Postersession 487. Antiproliferative Effect of Interferon and Hyperthermia / T. Satoh et al. / p479～479
Postersession 488. Not Received / /
Postersession 489. Multidisciplinary Treatment with Combined Hyperthermia, Radiation and Chemother-apy--Analysis of Prognostic Factors, and Predicted Prognoses by Multivariate Analysis / M. Endow et al. / p479～479
Postersession 490. Clinical Evaluation of Total-Body Hyperthermia Combined with Anticancer Chemo-therapy for Far-Advanced Miscellaneous Cancer in Japan / M. Maeta et al. / p480～480
Postersession 491. Neutralization Test with Clonogenic Assay / K. Okamoto et al. / p480～480
Postersession 492. Combination Chemotherapy Evaluated by Human Tumor-Clonogenic Assay / K. Suzuki et al. / p480～480
Postersession 493. Comparative Study of Antitumor Activity and Myelosuppression of Three Platinum Complexes by HTCA and CFU-c Assay / H. Takahashi et al. / p481～481
Postersession 494. Clinical Utility of the Scintillation Assay / N. Tanigawa et al. / p481～481
Postersession 495. In vitro Chemosensitivity of Various Human Tumors Evaluated by Succinate Dehy-drogenase Inhibition (SDI) Test / Y. Maehara et al. / p481～481
Postersession 496. Significance of the Measurement of Serum and Urinary /β₂-Microglobulin in Cancer Chemotherapy / E. Araki et al. / p482～482
Postersession 497. Fundamental Research about Application of Pulsing Magnetic Field to the Cancer Therapy / Y. Omote et al. / p482～482
Postersession 498. Cancer Chemotherapy with Oriental Medicine / A. Sato et al. / p482～482
Postersession 499. Effect of UFT, FT and PSK on Immunological Competent Cells / S. Nakao et al. / p483～483
Postersession 500. The Effect of OK-432 to the Intratumor 5-FU Concentration after UFT Administration / Y. Yamamoto et al. / p483～483
Postersession 501. Clinical Study on UFT.MMC Combination Chemotherapy for Cancer of Digestive Organ / S. Orii et al. / p483～483
Postersession 502. Concentration and Enzyme Activity in the Tissues of Patients on Oral Administration of 5-FU Derivative (5′-DFUR) / T. Ohno et al. / p484～484
Postersession 503. Not Received / /
Postersession 504. Effects of High-dose 5FU (or FT-207) Therapy Combined with Intravenous Hyper-alimentation for the Recurrent Retroperitoneal Malignancies of Alimentary Tract / H. Nagano et al. / p484～484
Postersession 505. Clinical Pharmacokinetics of Cisplatin / T. Ohno et al. / p484～484
Postersession 506. Renal Dysfunction in Mice Cured of Ascites Tumor by the Use of Large Dose of CDDP / K. Komatsu et al. / p485～485
Postersession 507. Improved Control of Cisplatin-induced Emesis with Combination of Moderated Dose Metoclopramide, Dexamethasone, Droperidol, and Diphenhydramine / K. Iwamoto et al. / p485～485
Postersession 508. Anticancer Efficacy of Cis-Platinum Administered by Intracavitary Injection / K. Kikuchi et al. / p485～485
Postersession 509. As Density Shift of Cisplatin and CQ in the Ascites of Peritonitis Carcinomatosa / T. Oda et al. / p486～486
Postersession 510. Cisplatin in the Treatment of Advanced Cancer of GI Tract / H. Kitagawa et al. / p486～486
Postersession 511. Early Phase II Study of Cisplatin in Gastric and Colon Cancer / K. Ishibiki et al. / p486～486
Postersession 512. Cisplatin-Based Combination Chemotherapy in the Treatment of Patients with Malignancy--Regimen, Prevention of Side Effect and Combination of Immunotherapy / K. Yamada et al. / p487～487
Postersession 513.Clinical Evaluation of Serum Sialosyl SSEA-1 Antigen as a Tumor Marker / Y.Ariyoshi et al. / p487～487
Postersession 514.Effects of Radiotherapy on Lymphocyte Subsets in Patients with Lung Cancer A Preliminary Result of Two Color Analysis Using Fluorescence-labeled Monoclonal Antibodies / S.Nakatsugawa et al. / p487～487
Postersession 515.Radiotherapy for Stage III Non-Small Cell Carcinoma of the Lung / J.Watarai et al. / p488～488
Postersession 516.Suitable Radiation Dose in Radical Radiotherapy for Lung Cancer / N.Nakajima et al. / p488～488
Postersession 517.Randomized Prospective Study of Radiation versus Radiation plus ACNU in Non-Small-Cell Lung Cancer / S.Hashimoto et al. / p488～488
Postersession 518.The Changes of Electrophoretic Mobility Pattern and OKT8/OKT4 Ratio in Periph-eral Blood Lymphocytes of the Lung Cancer Patients / Y.Nishimura et al. / p489～489
Postersession 519.Synergistic Antitumor Effects of OH-1 H-7-1 Fraction(Natural-human TNF)and Mouse Interferon Beta on Lewis Lung Carcinoma / S.Itano et al. / p489～489
Postersession 520.A Phase I/II Study of Recombinant Interleukin 2 (rIL-2) / T.Sano et al. / p489～489
Postersession 521.Bromodeoxyuridine(BrdU)Labeling Method for the Study of Cancer Cell Cycle Analysis / T.Fujikane et al. / p490～490
Postersession 522.In vitro Chemosensitivity Test:Mini-scintillation Assay(Mini-hybrid Assay)Using Double Soft Agar Method / H.Nakano et al. / p490～490
Postersession 523.Subrenal Capsule Assay in Human Lung Cancer / S.Kudoh et al. / p490～490
Postersession 524.Evaluation of the Combination Chemotherapy Including Cis-platinum by the Checker Board Analysis / K.Lee et al. / p491～491
Postersession 525.Experimental and Clinical Study of Intrapleural Administration of CDDP and Ara-C for Malignant Pleural Effusion / K.Yonezawa et al. / p491～491
Postersession 526.A Randomized Comparison between CDDP+ADR+CPA and CDDP+PLM+VP16 in Extensive Non-Small Cell Lung Cancer / S.Yoneda et al. / p491～491
(CAV)in the Treatment of Small Cell(SCLC)and Non-small Cell(NSCLC)Lung Cancer / Y.Yamaji et al. / p492～492
Postersession 528.Experimental Studies on the Concentration of 5-Fluorouracil in Various Tissues Following Nebulization Chemotherapy / S.Koyama et al. / p492～492
Postersession 529.A Phase II Study of UFT for Non-small Cell Lung Cancer / E.Shimizu et al. / p492～492
Postersession 530.A Newly Designed Sustained Release Anti-cancer Chemotherapy with Use of Silicone / K.Matsumura et al. / p493～493
Postersession 531.The Results of Multidisciplinary Treatment for Non-small Cell Lung Cancer(NSCLC) / M.Murakarmi et al. / p493～493
Postersession 532.Photodynamic Therapy for Severe Metaplasia of the Lung / K.Yoneyama et al. / p493～493
Postersession 533.Panpleuropneumonectomy for Carcinomatous Pleuritis due to Lung Cancer / T.Sakai et al. / p494～494
Postersession 534.The "Quality of Life"of Patients with Lung Cancer / S.Negoro et al. / p494～494
Postersession 535.A Study of Double Cancer Involving Lung and Other Organs / Y.Uchiyama et al. / p494～494
Postersession 536.Classification and Treatment of Anterior Mediastinal Germ Cell Tumors / M.Irako et al. / p495～495
Postersession 537.Clinical Evaluation of Primary Pulmonary Malignant Lymphoma / Y.Matsuzaki et al. / p495～495
Postersession 538.Basic and Clinical Studies on Adoptive Immunotherapy(AIT)with LAK Cells / H.Suzuki et al. / p495～495
Postersession 539.Comparative Data on Cytophotometric DNA in Malignant Lesions of the Esophagus in the Chinese and Japanese / Y.Koga et al. / p496～496
Postersession 540.Evaluation of Tumor-markers in the Serum of Patients with Carcinoma of the Esophagus / T.Kawaguchi et al. / p496～496
Postersession 541.The Serum Squamous Cell Carcinoma Antigen(SCC)Level of the Esophageal Squamous Cell Carcinoma / K.Ikeda et al. / p496～496
Postersession 542.Efficacy of MRI in Detection of the Extent of Advanced Esophageal Cancer / H.Kubo et al. / p497～497
Postersession 543.Low Dose Rate Teletherapy as Boost Therapy for Esophageal Carcinoma / S.Yamada et al. / p497～497
Postersession 544.The Role of Radiation Therapy in the Surgical Treatment of Cancer of the Esophagus / A.Okazaki et al. / p497～497
Postersession 545.Effect of Tumor Bearing,Aging and Malnutrition on the Augmentation of Murine Splenic NK Activity by in vivo Treatment with OK-442 / K.Shimoda et al. / p498～498
Postersession 546.Efficacy of Subrenal Capsule Assay for Esophageal Cancer / H.Fukui et al. / p498～498
Postersession 547.Subrenal Capsule Assay for Esophageal Cancer / M.Terashima et al. / p498～498
Postersession 548.CDDP Administration for the Treatment of Advanced Esophageal Cancer / T.Shimokawa et al. / p499～499
Postersession 549.A Study of Preoperative Administration of CDDP in 10 Cases of Esophageal Carcinoma / H.Shimizu et al. / p499～499
Postersession 550.Serum Levels and Organ Distribution of Platinum Following Administration of CDDP in the Esophageal Cancer / S.Shiraha et al. / p499～499
Postersession 551.Multimodality Treatment Combined with Radiotherapy and Chemotherapy for Inoper-able and Postoperative Recurrent Carcinoma of the Esophagus / M.Shinoda et al. / p500～500
Postersession 552.Combination of Polychemotherapy and Radiation for Esophageal Cancer / H.Inaba et al. / p500～500
Postersession 553.Clinical Study of Preoperative Chemotherapy for Advanced Esophageal Cancer / K.Namatame et al. / p500～500
Postersession 554.Experimental Study of Thermochemotherapy for Human Esophageal Carcinoma Cells / M.Saitoh et al. / p501～501
Postersession 555.Effects of Pre-Operative Hyperthermia alone for Patients with Esophageal Cancer / T.Ohmori et al. / p501～501
Postersession 556.Local Hyperthermia by Endoradiotherm 100A Combined with Polychemotherapy in Esophageal Cancer / Y.Yamashita et al. / p501～501
Postersession 557.Effects of Hyperthermo-Chemo-Radiotherapy on KSE-1,a Newly Established Human Squamous Cell Line Derived from Esophageal Carcinoma / H.Matsuoka et al. / p502～502
Postersession 558.Evaluations on Thermo Methods with RF Wave Inner Electrode against Carcinoma of the Esophagus / K.Higashino et al. / p502～502
Postersession 559.Cell Kinetic Reactions of Human Esophageal Cancer Cells in vitro(SGF-5)Following Administration of Anticancer Agents or Hyperthermia:Analysis by FCM Using Anti-BrdUrd Monoclonal Antibody / S.Munakata et al. / p502～502
Postersession 560.Not Received / /
Postersession 561.Resection versus Irradiation in the Treatment of Dysphagia in Esophageal Carcinoma / R.Kirchner et al. / p503～503
Postersession 562.Clinical Evaluation of Pancreas Tissue Antigen(PaA) / J.Furukawa et al. / p503～503
Postersession 563.Relation of Tumor Markers(CEA,CA19-9)and Glycosylated Hemoglobin(HbA₁)in Diabetic Patients / T.Kurihara et al. / p503～503
Postersession 564.The Study of the Tumor Marker in the Malignany of Liver,Bile Duct and Pancreas / T.Makino et al. / p504～504
Postersession 565.Production and Characterization of Monoclonal Antibodies,FP-1,FP-2 and FP-3,against Human Fetal Pancreas / K.Shibata et al. / p504～504
Postersession 566.Not Received / /
Postersession 567.A Role of Radiation Therapy in the Treatment of Pancreatic Cancer / T.Ogino et al. / p504～504
Postersession 568.A Trial of Intraoperarive Administration of Neocarzinostatin in Subserosal of Duode-num for Pancreatoduodenal Cancer / Y.Hase et al. / p505～505
Postersession 569.In vivo Induction of Lymphokine-activated Killer(LAK)Cells by Infusion of Interleu-kin 2(IL-2)into the Splenic Artery / H.Takagi et al. / p505～505
Postersession 570.Combined Modalitytherapy of the Pancreatic Cancer (Mainly Hyperthermia) / S.Akaishi et al. / p505～505
Postersession 571.Acute Suppurative Cholangitis due to Carcinoma of Pancreas and Biliary Truct / A.Yamaguchi et al. / p506～506
Postersession 572.Clinical Significance of Bile Carcinoembryonic Antigen(CEA)and Bile Carbohydrate Antigen(CA19-9)in Biliary Disease / K.Odani et al. / p506～506
Postersession 573.Measurement of PIVKA-II on HCC Using E-1023 / R.Ohmizo et al. / p506～506
Postersession 574.Clinical Evaluation of MRI for Hepatoma / T.Kato et al. / p507～507
Postersession 575.A Study on Cases Having Undergone Early Angiography and TAE Therapy after Hepatectomy / Y.Hiraide et al. / p507～507
Postersession 576.The Evaluation of Intrahepatic Recurrence of Resected Hepatocellular Carcinoma / H.Nishio et al. / p507～507
Postersession 577.The Significance of Pre-operative TAE for the Patients with HCC / S.Imaoka et al. / p508～508
Postersession 578.Not Received / /
Postersession 579.Treatment and Survival Rate of Hepatocellularcarcinoma / H.Sakai et al. / p508～508
Postersession 580.Studies on the Surgical Treatment and Chemotherapy of Liver Metastases / I.Mizuno et al. / p508～508
Postersession 581.Radiation Therapy of Biliary Duct Malignant Tumor / K.Nakagawa et al. / p509～509
Postersession 582.The Role of Radiation Therapy in the Management of Biliary Tract Tumor / T.Kamada et al. / p509～509
Postersession 583.Effects of Anticancer Drugs on Hepatic Fibrosis in Rats with Carbon Tetrachloride Induced Hepatic Dysfunction / J.Ono et al. / p509～509
Postersession 584.The Effect of Etoposide(Et)on Primary Hepatocellular Carcinoma(HCC) / N.Tanaka et al. / p510～510
Postersession 585.FT,5FU,and Uracil Concentration in Blood,Bile,and Tissue of Hepatoma with Liver Cirrhosis after Oral Administration of UFT / S.Oguma et al. / p510～510
Postersession 586.Clinical Studies of UFT for Hepatocellular Carcinoma / G.Yamaguchi et al. / p510～510
Postersession 587.Chemotherapy for Hepatocellular Carcinoma / H.Nasu et al. / p511～511
Postersession 588.Phase II Study of Intravenous Mitoxantrone in Patients with Advanced Hepatocellular Carcinoma / T.Yoshida et al. / p511～511
Postersession 589.Clinical Study on Cisplatin in the Treatment of Hepatocellular Carcinoma / K.Mitsuyama et al. / p511～511
Postersession 590.Chemotherapy of Nonresectable Liver Carcinoma by Portal Infusions Using Subcuta-neous Portal Reservoir(SCPR) / K.Akimaru et al. / p512～512
Postersession 591.Experimental Study on Cryo-chemotherapy / T.Morita et al. / p512～512
Postersession 592.The Features of Liver Metastasis of Breast Cancer on Imaging and Its Response to Arterial Infusion Chemotherapy / T.Kakuta et al. / p512～512
Postersession 593.Clinical Evaluation of Local Infusion Chemotherapy for Metastatic Liver Carcinoma Using Port-A-Cath--Determination of Chemotherapeutic Agents by Subrenal Capsule Assay / E.Yokoyama et al. / p513～513
Postersession 594.Intrahepatic Arterial Infusion Chemotherapy for the Unresectable Malignant Tumors of Liver Using Implantable Infusion Pump / Y.Tsuji et al. / p513～513
Postersession 595.Transcatheter Chemo-Embolization Using Adriamycin for Unresectable Hepatocel-lular Carcinoma:Therapeutic Evaluation by Comparison with Intra-Arterial One Shot Injection of Adriamycin / M.Itsubo et al. / p513～513
Postersession 596.Effective Chemotherapy for Primary or Metastatic Malignant Liver Tumor with Intra-Hepato-Arterial Infusions of Cis-Diamminedichloroplatinum(II)plus 5 Fluorour-acil / T.Wakatsuki et al. / p514～514
Postersession 597.A New Approach to Chemoembolization Therapy for Hepatoma Using Ethiodized Oil,Cisplatin and Gelatin Sponge (Sandwitch Therapy) / Y.Sasaki et al. / p514～514
Postersession 598.Arterial Embolization of Liver Malignancies with FudR-Lipiodol / Y.Yamashita et al. / p514～514
Postersession 599.Clinical Evaluation of Transcatheter Chemoembolization for Malignant Hepatic Tumors with Degradable Starch Microspheres / K.Itani et al. / p515～515
Postersession 600.A Review of Predictable Factors in the Cases of Serious Complications within One Month after TAE for Hepatocellular Carcinoma / S.Nakatsuka et al. / p515～515
Postersession 601.The Effects of Arterial Chemoembolization with Degradable Starch Microspheres Combined with Hyperthermia in the Treatment of Liver Tumors / T.Murata et al. / p515～515
Postersession 602.Local Radiofrequency(RE)Hyperthermia for Metastatic Liver Tumor / S.Takegawa et al. / p516～516
Postersession 603.Not Received / /
Postersession 604.Multidisciplinary Treatment for Advanced or Recurrent Liver Cancer Using Micro-wave Tissue Coagulator(The 2nd Report) / H.Kodama et al. / p516～516
Postersession 605.Phase II Study γ-Interferon(INF-γ)for Hepatocellular Carcinoma(HCC) / M.Yoshino et al. / p516～516
Postersession 606.Anticancer Effects of a Lipophilic Prodrug of 5-fluoro-2′-deoxyuridine(FUdR) Dissolved in an Oily Lymphographic Agent(Lipiodol Ultra-Fluid) on Hepatic Cancer by Injection into Hepatic Artery / S.Fukushima et al. / p517～517
Postersession 607.Effects of Ethanol Injection Therapy on Hepatocellular Carcinoma / A.Furusawa et al. / p517～517
Postersession 608.A Case Report of Fibrolamellar Carcinoma of the Liver with Bile Duct Invasion / H.Taniura et al. / p517～517
Postersession 609.New Multimodality Therapy on Malignant Tumors of Biliary Tract / M.Mukai et al. / p518～518
Postersession 610.Preoperative Therapy of Bladder Cancer / T.Nasu et al. / p518～518
Postersession 611.Preoperative Thermoradiotherapy for Invasive Bladder Cancer / K.Akuta et al. / p518～518
Postersession 612.The Role of Pre-operative Intra-arterial Doxorubicin Chemotherapy in Combination with Low-dose Irradiation for Bladder Cancer / H.Yokozeki et al. / p519～519
Postersession 613.Conservative Treatment with RF Hyperthermia for Bladder Cancer / R.Noguchi et al. / p519～519
Postersession 614.Histological Study and Analysis of Blood and Tissue CDDP Concentration Value after Intra Arterial Infusion Therapy for Bladder Cancer / Y.Aota et al. / p519～519
Postersession 615.NK Cell Activity of Urologic Cancer Patients after Chemoembolization / R.Abe et al. / p520～520
Postersession 616.Monoclonal Antibodies to Human Bladder Cancer Cells(The Third Report) / N.Takahashi et al. / p520～520
Postersession 617.MVP-CAB Regimen for Advanced Transitional Cell Carcinoma of the Urinary Tract / S.Den et al. / p520～520
Postersession 618.Percutaneous Treatment for Renal Pelvic Tumor / M.Yanagawa et al. / p521～521
Postersession 619.Photodynamic Therapy for Superficial Bladder Tumors / T.Misaki et al. / p521～521
Postersession 620.Whole Bladder Wall Photodynamic Therapy Using a Newly Designed Light-scattering Device for Superficial Multicentric Bladder Tumors with/without Carcinoma in Situ of the Bladder / T.Uchibayashi et al. / p521～521
Postersession 621.Combination Therapy of Microwave Coagulation and Intracavitary Irradiation for Bladder Cancer / T.Harada et al. / p522～522
Postersession 622.Clinicopathological Analysis of Patients with Bladder Tumor Treated by Partial Cystectomy / H.Takada et al. / p522～522
Postersession 623.New En Bloc Radical Cystectomy for Invasive Bladder Carcinoma / Y.Hiraoka et al. / p522～522
Postersession 624.Criteria of the Prophylactic Urethrectomy in Male Patients Undergoing Radical Cystectomy for Bladder Carcinoma / K.Hasuo et al. / p523～523
Postersession 625.The Quality of Life in Male Patients with Bladder Cancer after Total Cystectomy with Ileal Conduit:Results of Questionnaire Surveys to Compare the Impact of Treatments / M.Miyakawa et al. / p523～523
Postersession 626.Urethral Recurrence of Bladder Cancer Following Cystectomy / H.Kakizaki et al. / p523～523
Postersession 627.Histopathological Prognosticating Features after Radical Cystectomy / N.Sakakibara et al. / p524～524
Postersession 628.Continent Urinary Reservoir for Bladder Carcinoma / N.Honda et al. / p524～524
Postersession 630.Prophylactic Intravesical Instillation Chemotherapy for Post-operating Superficial Bladder Cancer / Z.Kataumi et al. / p525～525
Postersession 631.Intravesical Etopic Recurrence of Bladder Tumors / S.Iwamuro et al. / p525～525
Postersession 632.Treatments and Actual Status of Bladder Cancer in Elderly Patients / I.Hirano et al. / p525～525
Postersession 633.Two Cases of Squamous Cell Carcinoma of the Bladder / K.Kumagai et al. / p526～526
Postersession 634.Secondary Foci of Primary Tumors of the Bladder in the Upper Urinary Tract:Report of 4 Cases / T.Mishina et al. / p526～526
Postersession 635.Surface Marker Analysis of Solid Tumor Cells / K.Tabuchi et al. / p526～526
Postersession 636.Measurement of Blood NCC-ST-439 Antigen by Enzyme Immunoassay Kit(EIA Kit) and Evaluation of It as a Tumor Marker / E.Hanada et al. / p527～527
Postersession 637.Combined Antitumor Effect of MMC and Polyl:C against Murine Tumor Implanted in Mice / M.Sakurai et al. / p527～527
Postersession 638.Effect of TCA Therapy on Host Parameter (Basic Investigation) / K.Orimo et al. / p527～527
Postersession 639.An Immunological Cancer Therapy Trial Sensitized by Tumor Cell Derived Carbo-hydrate Antigen(TCA) / Y.Suzuki et al. / p528～528
Postersession 640.Effect of TCA Therapy on Host Parameter (Clinical Investigation) / K.Ietomi et al. / p528～528
Postersession 641.Experimental Studies of Adoptive Immunotherapies with Activated Cells by Inter-feron,Interleukin-2 and OK-432 on Human Gastric Cancers SC-6 and H-111 Xeno-graft in Nude Mice / M.Yamaguchi et al. / p528～528
Postersession 642.IFN-γ Production in Human Peripheral Mononuclear Cells in Response to PHA and K562 Cells / R.Izutani et al. / p529～529
Postersession 643.Not Received / /
Postersession 644.Lymphocyte Functions in the Patients with Cancer / S.Yamaga et al. / p529～529
Postersession 645.Suppressor Cell Activity against Natural Killer Cell Activity in Cancer Patients / E.Yanagawa et al. / p529～529
Postersession 646.Combination Chemoimmunotherapy of Advanced Cancer with MMC and OK432 / S.Arinaga et al. / p530～530
Postersession 647.Studies on Adoptive Immunotherapy with Lymphokine Activated Killer(LAK)Cell for Clinical Use / N.Terata et al. / p530～530
Postersession 648.Experimental Study on Adoptive Immunotherapy Using LAK Cells--Anti-tumor Activities of LAK Cellsin in vitro and in vivo Assays / H.Takao et al. / p530～530
Postersession 649.Clinical Efficacy of Systemic and Local Transfer of LAK Cells (Pilot Study) / S.Nojiri et al. / p531～531
Postersession 650.A Study Concerning the Practical Use of LAK Cells / M.Ohta et al. / p531～531
Postersession 651.Adoptive Immunotherapy for Advanced Cancer Patients with Lymphokine Activated Killer Cells / H.Yamada et al. / p531～531
Postersession 652.Pre-and Post-operative Changes in Killer Activity of Peripheral Blood Lymphocytes and LAK Cells of Gastric and Colonic Cancer Patients / S.Tachibana et al. / p532～532
Postersession 653.The Antitumor Effects and the Mechanisms of Bacterial Endotoxin(LPS) / M.Horisawa et al. / p532～532
Postersession 654.The Statistical Analysis of Advanced Cancer Patients in Treatment with an Extract from Human Tubercle Bacilli(S.S.M.) -Report VIII / K.Fujita et al. / p532～532
Postersession 655.OK432-induced Production of IFN-γ in Peripheral Mononuclear Cells from Healthy Subjects and Patients with Cancer / H.Matsumoto et al. / p533～533
Postersession 656.Evaluation of the Repeated Local admlinistration of OK432 against Malignancies / M.Ochiai et al. / p533～533
Postersession 657.Role of Impaired NK Cell and Macrophage Activities in Enhancement of Tumor Metastasis and Its Prevention by OK-432 Administration--Experimental Study in a Rat Metastatic Lung Tumor Model / H.Kida et al. / p533～533
Postersession 658.Intracavitary Injection of OK-432 with Fresh Frozen Plasma against Carcinomatous Peritonitis and Pleuritis--Arachidonate Metabolites and Chemotaxisis / H.Kato et al. / p534～534
Postersession 659.Induction of Activated Natural Killer Cells from Murine Spleen Cells Primed in vivo and Subsequently Challenged in vitro with Streptococcal Preparation OK432 / H.Yamaue et al. / p534～534
Postersession 660.Clinical Analysis of Killer Cell Augmentation in Digestive Organ Cancer Patients Treated with OK432 / M.Zeniya et al. / p534～534
Postersession 661.Effect of Hyperthermia on the Antiproliferative Activities of Human Interferons and Antineoplastics / K.Yoneda et al. / p535～535
Postersession 662.In vivo Antiproliferative Effect of Recombinant Human Interferons,Alone and in Combination / Y.Naomoto et al. / p535～535
Postersession 663.Combined Effect of Human Recombinant Interferon-γ and Adriamycin on Experi-mental Pulmonary Metastasis in Nude Mice / H.Kondo et al. / p535～535
Postersession 664.In vitro Enhancement of Cytotoxicity of Human Peripheral Blood Lymphocytes with Recombinant Interleukin 2 and Interferon Mixture(α+β+γ)against Human Colon Carcinoma Cell Line SW1116 / Y.Kimoto et al. / p536～536
Postersession 665.Regulation of Prostaglandin E₂ and Interleukin-1 Production of Cancer Patients by BRM Theraphy / R.Asai et al. / p536～536
Postersession 666.Phase I and Early Phase II Studies of PT-050 (Recombinant Human Tumor Necrosis Factor:rHu-TNF) / T.Taguchi et al. / p536～536
Postersession 667.Anti Tumor Therapy to Metastatic Colon Carcinoma in Liver by Induction of Endogenous Tumor Necrosis Factor / K.Takagi et al. / p537～537
Postersession 668.Anti-tumor Therapy for Metastatic Urological Cancer by Induction of Endogenous TNF / M.Kato et al. / p537～537
Postersession 669.Anti-tumor Therapy by Induction of Endogenous Tumor Necrosis Factor(TNF)in Gynecologic Cancer / K.Dobashi et al. / p537～537
Postersession 670.Immunological Responsiveness under Immune-surveillance Therapy against Terminal Cancer of Digestive Organs / I.Sato et al. / p538～538
Postersession 671.Role of Serum Factors in Impairment of Host Immunocompetence during the Early Post-cryosurgical Period--Experimental Study / H.Niwa et al. / p538～538
Postersession 672.Not Received / /
「国立国会図書館デジタルコレクション（雑誌）」より
書名
日本癌治療学会誌 = The journal of Japan Society of Clinical Oncology
